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promoveren doe je niet alleen en ik wil graag iedereen bedanken die op één of 
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De verhuizing naar 'achter de klapdeuren' was de volgende stap. Met de hele groep 
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doordachte taktiek meestal de rode lantaarn labjas droeg het volleyballen tijdens de 
lunch en op het ß-faculteiten toernooi de biljart- bowl- (midget)golf- en 
dartcompetities het uitstapje naar Winterberg (20 uur reizen 2 uur skiën bevroren 
lichaamsdelen en uitgevlokte diesel) de filmavonden en Donatello s (delen we nog 
een tweede diavolo?) Hulde aan alle organisatoren 
De wetenschappelijke activiteiten zowel intern als extern zal ik ook nooit vergeten Het 
jaarlijks terugkerende Lunteren de studiereis naar de oostkust van de Verenigde 
Staten in 1990 en de Japan-tour in 1992 waarbij het organiseren even waardevol was 
als het deelnemen Alle mede-reizigers bedankt1 
Alle familie vrienden collega s en bekenden wil ik graag bedanken voor de getoonde 
belangstelling en het begrip dat we een tijdje van het sociale toneel waren 
verdwenen Nog even en we draaien weer volop mee1 
En nu komt het moeilijkste deel Voor alle bovengenoemde personen was het redelijk 
eenvoudig te omschrijven waarvoor ik ze dankbaar ben maar voor jou Jeannette is 
dat toch wat gecompliceerd Een drukke baan veel in het buitenland en daarnaast 
een proefschrift schrijven in de weekeinden heeft zoveel tijd in beslag genomen dat 
alle leuke en eigenlijk noodzakelijke sociale activiteiten afgezegd moesten worden 
Alles wat je gedaan hebt hoe vanzelfsprekend het soms ook mocht lijken heeft er toe 
bijgedragen dat ik mij volledig op het proefschrift kon concentreren Samen hebben 
we het toch maar mooi klaar gespeeld 
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General introduction 
CHAPTER 
GENERAL INTRODUCTION 
1.1 Background 
Macrocyclic lactones (macrolides) are naturally occurring compounds which often possess biological activity. The synthesis of these compounds has received considerable attention in 
recent years. Several macrolides have been synthesized (see figure 1.1 ), using 
a strategy based on the convenient conversion of α,β-epoxy diazomethyl 
/ 
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Figure 1.1 
The required chirality was introduced by making effect ive use of the Sharpless 
epoxidat ion6 of an allylic a lcohol derivative (Scheme 1.1). 
1 
\A/ OH OH 
R, Ä Л Η ОН 
R
-7v^Y° E t 
a. L-(+)-Diethyltartrate, Ti(0/-Pr)4. /-BuOOH. CH2CI2, -20°C; b.(i) (COCI)2, DMSO, (ii) 
NaCI02; с (i) CICC^Bu/EtaN; (ii) CH2N2; d. hv. EtOH. 
Scheme 1.1 
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General introduction 
A different approach to the synthesis of macrolides is subject of this thesis, 
namely using carbohydrates as the principle source of chirality in the starting 
material.7 The main focus will be on the total synthesis of (+)-aspicilin. 
Aspicilin was isolated in 1900 by Hesse6 from species of a lichen [Aspicilia 
gibbosa) and later from other species9 of the Lecanoraceae family e.g. 
Aspicilia Calcarea and Aspicilia caesiocinerea, and from species of the 
Roccellaceae family found on the Moroccan coast, Roccella fucoides. and 
of Ramalina eck/oniifound on the Chilean coast. 
Lichens are well known for the diversity of secondary metabolites that they 
produce. These products can be sub-divided into a number of major 
categories of structural classes10, e.g., monocyclic phenol derivatives, 
depsides, depsidones, dibenzofurans, xanthones, anthraquinones, pulvinic 
acids, fatty acids and triterpenes. The fact that aspicilin was the first 
macrocyclic lactone ever found in lichens could be a reason that almost 75 
years later finally the structure of aspicilin was elucidated.n·1 2 
The absolute configuration of (+)-aspicilin was determined1 3 to be AR,5S,6R,\7S 
in 1985. Since 1987 several syntheses of both (+) and (-) aspicilin have been 
reported. An overview of the various non-carbohydrate based syntheses that 
have been described are presented chronologically here. The carbohydrate-
based syntheses will be discussed in more detail in chapters 2 and 3, 
respectively. 
In 1987 Zwanenburg e/Ό/.5 reported the first total synthesis of aspicilin starting 
from /?,#-diethyl L-tartrate 6 which eventually led to the optical antipode of 
the natural product. This starting material was arbitrarily chosen because at 
the start of this synthesis project the absolute configuration of the natural 
3 
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aspicilin was not known C o m p o u n d 6 was c o n v e r t e d by a multi-reaction 
sequence (scheme 1 2) into the allyl a lcohol 7 A Sharpless epoxidat ion, 
subsequent silylation of the epoxy a lcohol, reduct ive debenzylat ion a n d 
oxidation (Swern) of the free hydroxy group g a v e the a l d e h y d e 8 This 
a l d e h y d e was required for react ion with phosphonium salt 11 m a Wittig 
reaction ( vide infra] 
н% Ри a f о ^ Ч g j ~ ^ 
/-\ ^ 
ЕЮОС COOEt 
BnO 
6 7 8 
О 
k-m *·..,, 
H O C H 2 — = — Η »• T H P O ( C H 2 ) 6 Z Z Η *~ Br P h 3 P * ( C H 2 ) 6 -
o-s 
9 10 11 
O TBDMS 
— f 
OBn 
a (MeO)2CMe2 p-TosOH (96%) b L1AIH4 (85%) с NaH DMF PhCH2Br (72%) d Swern 
oxidation (85%) e (EtO)2P(0)CH2COOEt LiCI /-Pr2EtN MeCN (90%) f /-BU2AIH (100%) 
g Sharpless epoxidation (/-BuOOH Ті(ОлРг)4 and D(-) DIPT (85%) h /BuMe2SiCI 
imidazole (87%) 1 H2(Pd) (100%) j Swern oxidation(81%) к LiNH2 (2equiv ) NH3(hq ) 
CsHiiBr (85%), I K+ NH (CH2)3-NH2 (КАРА) NH3 (liq ) (90%) m DHP p-TosOH (96%) η 
BuLi HMPAAHF R (+) 2-methyloxirane (55% + 30% s m ) о NaH BnBr(80%+16% 
s m ) ρ MeOH p-TosOH 20°C (100%) q p-TosCI pyridine (95%) r LiBr acetone 
(93%) s Tnphenylphosphine MeCN (89%) 
Scheme I 2 
Coupling of 2-propynol 9 with 1-bromopentane g a v e the 2-octynol which 
was c o n v e r t e d into the 7-octynol using potassium 3-aminopropyl a m i d e as an 
"acetylenic zipper" Treatment of the foregoing material with 
dihydropyran//>toluenesulfonic a c i d g a v e the p r o t e c t e d alkynol derivative 
10 (scheme l 2) 
4 
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The required asymmetric phosphonium salt 11 was obtained via a coupling of 
the THP-protected alkynol 10 with (-)-(£)-methyloxirane [prepared from (-)-(i)-
ethyl lactate] After benzylation of the hydroxy group at the introduced chiral 
center, the THP-protected alcohol was converted, via the free alcohol, the 
tosylate and the bromide, into the phosphonium salt 11 (scheme l 2) 
The product of the Wittig coupling between compounds 8 and 11 was 
converted into epoxy diazomethyl ketone 13 which underwent a 
rearrangement in methanol upon irradiation (scheme 1 3) The hydroxy group 
in the resultant γ-hydroxy-a.ß-unsaturated ester was silylated and treatment 
with base gave the iecolactone needed for the Yamaguchi lactonization u 
The ring closure of the ¿ecolactone was accomplished using 2,6-
dichlorobenzoyl chloride instead of 2,4,6-tnchlorobenzoyl chloride originally 
employed by Yamaguchi u 
a
 JL 
8 + 11 »- B n C T ^ = — (CH2)r 
12 
y 
о 
TBDMS 
14 
a BuLi THF/HMPA (59%) b H2(Pd) (92%) с A c 2 0 pyridine DMAP (95%) d Bu<N+F 
THF 0°С(Ю0%) e Swern oxidation (98%) f NaCIO2(l00%) g /-BuOC(0)CI, EbN 
followed by CH2=N2 (60%) h hv (300 nm)/MeOH followed by /-BuMe2SiCI, 
imidazole DMF (46%+15% of unprotected alcohol at C(4)) ι LiOH THF/H20, 
followed by treatment with tartaric acid (98%) j 2 6-dichlorobenzoyl chloride EÍ3N, 
then DMAP PhCH3 ΔΤ (68%) к Bu<N+F THF (62%) I TFA MeOH/H20 (73%) 
Scheme ! 3 
*- (-)-aspicilm 
5 
Chapter 1 
After removal of the protecting groups of the formed lactone 15, (-)-aspicilin 
could be obtained in l% overall yield based on A'.A'-diethyl L-tartrate 6 as 
starting material (scheme 1.3). 
It should be noted that the closure of ieco-lactones to macrocyclic lactones 
has received much attention in the literature. The Yamaguchi method was 
successful in many cases, which can not be said for various other methods. 
In the same year (1987) that the paper from the Nijmegen group5 was 
published Quinkert et al described'5 the total synthesis of (+)-aspicilin using a 
photolactonization step as the ring-closing reaction (scheme l .4). 
Starting from l,9-nonanediol, one hydroxy group was converted into a 
bromide while the remaining hydroxy group was protected with dihydropyran 
to the corresponding tetrahydropyranyl ether 17. Coupling of compound 17 
with the anion of the methoxymethyl protected phenol and removal of the 
tetrahydropyranyl protecting group gave the free primary hydroxy group. This 
hydroxy group was converted, via the methylsulfonyl derivative, into the 
bromide 18. The hydroxy group at the asymmetric center of 19, which was 
introduced in a Grignard reaction of 18 with (i)-methyloxirane, reacted with 
dihydropyran to form a tetrahydropyranyl ether. Deprotonation with n-
butyllithium followed by treatment with diphenyl disulfide gave the phenyl 
sulfide derivative which was oxidized to the phenylsulfonyl group after all 
hydroxy protecting groups were removed. 
The oquinolacetate 20, required for the photolactonization, was prepared by 
a Lewis acid catalyzed oxidation with lead tetraacetate. Irradiation of 20 
gave the macrocyclic lactone 21 which was subsequently treated with 
sodium azide to give the (F,2)-diastereomer of 22 in 72% yield. 
6 
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о-мом о-мом он 
a b с f ι g ι I 
но-<сн2)9-он ^ вг-(снг)9 о-тнр *• ^ γ ^ γ - Ά ». ¿?*Y~*tfÇ^S^. 
16 17 ^ - ^ 18 ^ ^ 19 
ОН 
OAc 
CH3 O 
20 21 
O OH 
CH3 O CH3 O CH3 o 
22 23 (+)-aspicilin 
a СВГ4, РРЬз СНгСЬ; b DHP PPTS CH2CI2 с BuLi, TMEDA, PhO-MOM, THF, 80%; d. 
PPTS MeOH 98%; e MeS02CI, Et3N, CH2CI2 98%, f LiBr, THF, 98%, g. Mg, THF, (5)-
methyloxirane, 80% h. DHP, PPTS, CH2CI2 98%; ι BuLi/TMEDA, (PhS)2, 80%; j . 
TosOH НЮ, MeOH, 99%, к m-CPBA MeOH 86%, I Pb(OAc)4, BF3.Et20, EtOAc/MeOH, 
85%, m A¿Methyhmidazole (NMI) hv CCU, 69%; η NaNs, adogen 464, H2O, 72%; o. 
2,6 Di(/eA/-butyl)-4-methylphenol/DIBAH, toluene, 96%; p. Os04,pyridme, CH2CI2, 40%. 
Scheme 1 4 
Stereoselective reduct ion of the keto-function in 22, fo l lowed by 
stereoselective hydroxylation g a v e (+)-aspicilin in 6% overall yield based o n 
the coupl ing product of 17 with the methoxymethyl p r o t e c t e d phenol . 
The third group working on the synthesis of aspicilin, Solladié et al. reported1 6 
a total synthesis of the non-natural enant iomer in 1991 The chiral parts of the 
molecule were obta ined by asymmetric synthesis moni tored by a chiral 
sulfoxide group (scheme 1.5 1 6 and 1 7) 
7 
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Acid 24, was conver ted into the methyl /-butyl diester (thionyl chloride/7-butyl 
alcohol) which g a v e upon t reatment with the anion of (tf)-(+)-methyl />tolyl 
sulfoxide the ß-ketosulfoxide 25 Reduction of 25 with DIBAL resulted in the [S] 
8-hydroxysulfoxide 26 with a diastereoselectivity higher than 98% This 
diastereoselective reduct ion is the key step in this sequence (scheme 1.5) 
о о 
a b 
ОМе *- f-BuOjC 
f-Bu02C ^ - ^ ^ ^ ^ ^ ^ ^ v • 
26 
ОН О 
V 
Ar 
d-f 
O-TBDMS g
 h O-TBDMS 
27 28 
a SOCb, /-BuOH. (Me)2NPh b. LDA, (/?)-(+)-methyl p-tolylsulfoxide, с DIBAL THF, d 
H2, Raney-Ni, EtOH; e. TBDMSiCI, imidazole, DMF, f L1AIH4, THF· g PPh3 imidazole, I2, 
toluene, h. PPh3, СНзСЫ 
Scheme I 5 
Desulfunzation with Raney nickel, subsequent silylation (TBDMSiCI) of the 
hydroxyl function a n d reduction of the /-butyl ester group g a v e the m o n o 
protected nonanediol 27. The resultant free hydroxyl group was c o n v e r t e d 
conventionally into the iodide which upon treatment with tnphenylphosphine 
g a v e the phosphonium salt 28 (scheme 1.5) 
The second part of the molecule was assembled starting from dihydrofuran 
29 which was c o n v e r t e d into the hydroxythioacetal 30 in t w o steps (scheme 
8 
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1.6). Benzylation, hydrolysis of the thioacetal function and a Wittig Horner 
reaction of the product gave ester 31. 
The sulfoxide 32 was then obtained in the same way as described for 
compound 25 (vide suprd] except that the reduction of the keto group was 
performed in the presence of zinc chloride, which resulted in formation of the 
(£)-hydroxy diastereomer. The chelating effect of ZnCb is responsible for the 
formation of the ^-configuration in contrast to the ^configuration obtained in 
the absence of this salt. 
a
-b — ч ^ ч ^ . c-e /Vx^s^COjEt f.g Q J^. HO^^N 
OBn OBn 
29 30 31 
i-i 
^-
OH OMEM О OMEM 
* r^t\ OBn OAc OBn он OAc О / о OAc 
33 34 35 
a. TosOH, M e O H ; b. BF3.Et02, HS(CH2)3SH; с BnBr, TBAI; d . Mel , СаСОз, СНзСЫ-НЮ; е. 
NaH, THF, ( Е Ю ) 2 Р ( 0 ) С Н 2 С С Ш ; f. LDA, (/?)-(+)-methyl p-tolylsulfoxide, THF; g . DIBAL, 
ZnCb, THF; h. DIPEA, MEMCI, CH2CI2; ¡. АсгО, A c O N a ; j . L1AIH4, Et 2 0; к. А с г О , A c O N a ; I. 
OsCU, МезІМ(О), THF-НгО; m. M e 2 C ( O M e ) 2 , p-TosOH, DME; η. Raney-Ni, EtOH; о. Swern 
oxidation. 
Scheme 1.6 
Compound 33, obtained via protection (MEM) of the free hydroxy group of 
32, followed by a Pummerer rearrangement with acetic anhydride, was 
reduced to give the primary alcohol. Acetylation of the alcohol and 
subsequent catalytic osmylation gave 34 with a diastereoselectivity of 60%. 
9 
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Conversion of 34 into the acetonide and debenzylation gave an alcohol 
which was oxidized to the aldehyde 35 (scheme 1.6). 
The product 36 of the Wittig reaction between the ylid of phosphonium salt 
28 and the aldehyde 35 was hydrogenated, followed by saponification of 
the acetate (scheme 1.7). The free hydroxy group was converted into an 
aldehyde function (Swern) which underwent a Wittig-Horner reaction with 
triethyl phosphonoacetate to give the α,β-unsaturated ester. The hydroxy 
acid 37, required for the lactonization, was obtained via saponification of the 
ester and removal of the TBDMS-group with tetrabutylammonium fluoride. 
О OMEM О OMEM 
TBDMS-0 
36 
a. /τ-BuLi, THF; b. H2, Pd/C, EtOAc; с LiOH, MeOH-H20; d. Swern oxidation followed by 
Wittig-Horner with (ЕЮ)2Р(0)СН2ССШ, n-BuLi; e. LiOH, МеОН-НгО; f. TBAF, THF; g. 2,6-
dichlorobenzoyl chloride, Et3N, THF, then DMAP; h. BFa-EbO, HS-(CH2)2SH. CH2CI2. 
Scheme 1.7 
Lactonization, by means of the modified Yamaguchi procedure using 2,6-
dichlorobenzoyl chloride instead of the originally employed 2,4,6-
trichlorobenzoyl chloride, followed by removal of the protecting groups gave 
(-)-aspicilin in 3% overall yield, based on dihydrofuran 29 (scheme 1.6 ). 
The synthesis, published in 1994 by Sinha and Keinan17 (scheme 1.8), is based 
on the hexahydroxylation of a triene 39. All four chiral centers present in the 
target molecule were introduced via Sharpless asymmetric dihydroxylations 
(AD) using both AD-mix-a and AD-mix-ß. 
37 
10 
General introduction 
Triene 39 was obtained ¡η four steps from tridec-12-enal 38 ¡η 57% yield: (i) 
Wittig Horner reaction with triethyl phosphonoacetate, (ii) DIBAL-H reduction 
to the corresponding alcohol, (iii) PCC-oxidation to the pentadeca-2,14-
dienal and (iv) Wittig reaction with methylenetriphenylphosphorane (scheme 
1.8). 
The tetrahydroxy compound that was obtained after treatment of triene 39 
with AD-mix-β was converted into the diacetonide. Dihydroxylation of the 
remaining double bond with AD-mix-a followed by appropriate protection 
and deprotection steps resulted in compound 40 (scheme 1.8). 
f"""4·-' vx — " ^ o a " d 
38 
4 
^ Y ° H ЛоМЕм' 
n-p 
41 
39 
^ХУС 'OMEM 
40 
k-m 
q.r 
(+) aspicilin 42 
a. Triethyl p h o s p h o n o a c e t a t e , NaH, THF; b. DIBAL-H, THF; с. PCC-oxidation; d . 
methy l t r iphenylphosphonium b r o m i d e , л-BuLi, THF; e. AD-mix-ß, MeS02NH2, /-ВиОН-
НгО; f. DMP, a c e t o n e , TosOH; g . AD-mix-a, MeS0 2 NH 2 , /-ВиОН-НгО; h. TBDMSiCI, EtaN. 
DMAP; ¡. MEM-CI, ¿Pr2EtN, DMAP; j . TBAF, THF; k. Me2S, NCS, to luene, then Et3N; I. 
triethyl phosphonoace ta te , NaH, THF; m. AcOH, H20; п. (ЕЮ)зСМе, Me3SiBr, CH2CI2; 
o. BusSnH, AIBN, b e n z e n e ; p. LiOH, THF-H2O, then oxalic a c i d ; q . 2,4,6-trichlorobenzoyl 
chlor ide, Et3N, THF, then DMAP, to luene; r. (CH2SH)2, BF3-Et2d, СН 2 СІ 2 . 
Scheme 1.8 
lì 
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The α,β-unsaturated ester moiety was introduced via a Wittig-Horner reaction, 
after oxidation of the free hydroxy group of 40. Selective hydrolysis of the less 
stencally hindered acetonide, conversion of the resultant diol 41 into the 18-
bromo-17-acetoxy derivative, followed by debrominatlon and saponification 
gave the seco acid 42 
Yamaguchi type lactonization using the original 2,4,6-tnchlorobenzoyl 
chloride as the condensing agent and removal of the protecting groups 
gave (+)-aspicilm (in 6% overall yield) in 14 steps from the tridec-12-enal 38 
(scheme 1.8). 
Enders and Prokopenko also reported18 a total synthesis of (+)-aspicilin 
whereby three of the four stereogenic centers were generated by employing 
the so called SAMP/RAMP hydrazone method [(i) or (£)-1-ammo-2-(methoxy-
methyljpyrrohdine]. This sequence is depicted in the schemes 1 9 and 1.10 
The anion of SAMP hydrazone 43 reacted with 10-(/-butyldimethylsilyloxy)-
decyl bromide (prepared from 1,10-decanediol) to furnish the a-substituted 
SAMP hydrazone 44, which was ozonolyzed to give the ketone 45. 
N
 \ a V 
1 *-OCH 3 ы TBDMSO^y^Ji^ *-OCH3 »» TBDMSO JJr^^K. 
Г
 C 6 H 5 Г70Г^бН5 rVT ' 
b ° 
— - T ./ \ л A . 
C6H5 C H 3 .* CH,
 мл
 СНз 
3
 43 J 44 45 
C-e H O J W _ , O H f g Віч/vv-OTBDMS 
46 47 
a. ( I)ABULI, THF, -78°C; (и) Br(CH2)ioOTBDMS, 87%· b. Оз, CH2CI2, -78°C, 84%; с m-CPBA 
90%; d . LAH, ET2O, 74%; e. HF.Py. THF, 99%· f СВгд, РРЬз,СН2СІ2, 88%; g . TBDMSiCI, Et3N 
DMAP CH2CI2, 98%. 
Scheme 1.9 
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Reduction of the benzoate ester, formed in a Baeyer-Villiger oxidation by 
treatment of the ketone 45 with m-chloroperbenzoic acid, gave the 
corresponding secondary alcohol (alcohol at C(17) in the target macrolide). 
Removal of the silyl ether resulted in the diol 46. Regioselective bromination 
and subsequent protection of the free hydroxyl group gave the bromide 47 
(scheme 1.9). 
Subsequently, this bromide 47 was used as alkylating reagent in the coupling 
with the anion of RAMP hydrazone 48 followed by chloromethyl benzyl ether 
as the second alkylating reagent. Ozonolysis of the formed dialkylated 
hydrazone gave the ketone 49. Reduction of the keto function with L-
Selectride® introduced the fourth asymmetric center, in a diastereoselective 
fashion. 
, N ^ / 
Ν , a-c 
! '— OCH3 »· 
Λ 
°x° 
f\ 48 
BnO' 
X 
CH3 
OTBDMS 
49 
d f 
ОМОМ CH3 
"X 
HO' > < " y T-ToOTBDMS 
o^ ^o 
ah 
ОМОМ ÇH3 
Eto-Jl^íí?vJv^HÍ4 OTBDMS 
0 0 
л 
51 
ОМОМ ÇH3 
Ho'^^V^f^Ht'oH k,i (+) aspicilin 
V 
52 
a. /-BuU THF, -78°C, Br(CH2)ioCH(CH3)OTBDMS; b. /-BuLi, THF, -78°C, CICH2OBn; с. Оэ, 
CH2CI2, -78°C, 55% (step a-c); d. L-Selectnde, toluene, -78°C, 75%; e. MOM-CI, Hunig's 
base, CH2CI2, 25°C, 95%; f. Pd-C, H2, MeOH, 99%; g. (COCI)2, DMSO, CH2CI2, -78°C, 
EtsN, (ГС; h. Et02CCH2PO(OEt)2, o-BuLi, 0°C, 67% (step g+h); i. LiOH, THF, H2O, 40°C, 
95%; j . BU4NF, THF, 25°C, 98%; k. 2,4,6-trichlorobenzoyl chloride, Et3N, THF; DMAP, 
toluene, 90oC, 78%; I. (CH2SH)2,BF3.OEt2,CH2Cl2, 0°C, 75%. 
Scheme 1.10 
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Protection (MOM) of the formed hydroxy group, followed by debenzylation 
gave compound 50. Subsequent oxidation of the newly formed primary 
hydroxyl group gave the aldehyde which reacted in a Wittig Horner reaction 
with triethyl phosphonoacetate to give the α,β-unsaturated ester 51. 
The hydroxy acid 52, needed for the Yamaguchi lactonization, was obtained 
by saponification of the ethyl ester 51 and removal of the Abutyldimethylsilyl 
group. After lactonization of the resultant hydroxy acid 52 using 2,4,6-
trichlorobenzoyl chloride as the condensing agent, employed originally in this 
macrolactonization methodology, the protecting groups were removed and 
(+)-aspicilin was obtained in Ь% overall yield based on the SAMP hydrazone 
43. 
In 1995, Oppolzer et al. also reported" a synthesis of (+)-aspicilin using an 
alternative ring-closure reaction, i.e.. an asymmetrically catalyzed ω-alkynal 
ester cyclization (scheme l .11 ). 
The C(17) chiral center of the target molecule is present in the starting 
material (J)-methyloxirane 53. The asymmetric cyclization introduces the C(6) 
stereogenic center and regioselective epoxidation of an allylic alcohol 
installs the C(4) and C(5) chiral centers. 
Opening of the oxirane 53 with 10-(2-tetrahydropyranyloxy)decylmagnesium 
bromide, followed by esterification of the resulting alcohol with 4-pentynoic 
acid using DCC as the condensing agent, removal (TosOH/MeOH) of the 
tetrahydropyranyl protecting group and oxidation of the alcohol thus 
formed, gave the ω-alkynal ester 54. Cyclization of 54 in the presence of (1 R\-
(-)-dimethylaminoisoborneol gave the macrocyclic lactone 55 containing an 
allylic alcohol entity. Silylation of the free hydroxy group and application of 
the following sequence, (i) silylation of the lactone group, (ii) 
phenylselenation of the O-silylketene acetal, (iiij selenide oxidation, (iv) 
14 
General introduction 
selenoxide elimination and finally (v) fluoride mediated O-desilylation, 
introduced the C(2)-C(3) double bond to give 56 (scheme 1.11). 
e 
OH 
сЧ^^к
 f h 
Me,,. ^O 
53 54 55 
OH OAc 
°r v v S
 u °y^<ï\ k.m 
Me/, О J »» Me,, О J »~ (+)-aspicilm 
56 57 
a BrMg(CH2)ioOTHP Cu(COD)CI, b. 4-pentynoic acid, DCC, DMAP; с TosOH, MeOH; 
d (COCI)2 DMSO, NEt3, 76% (steps α-d); e. (c-hex)2BH, Et2Zn, (1 £)-(-)-
dimethylaminoisoborneol ((-)-DAIB), hexane, 60%; f. TBDMSiCI, DBU; g. LICA, THF; 
TBDMSiCI, HMPA PhSeBr; Magnesium monoperoxyphtalate (MMPP); h. HF.Py, 82% 
(steps f-h), ι /-BuOOH, VO(acac)2 77%· | Ac 2 0, NEt3, DMAP, 100%; k. BF3 Et20; I. aq 
NaHCOs, 81% (steps k+l), m. 1%HCI, MeOH, 97%. 
Scheme 1 11 
Regioselective epoxidation of the C(4)-C(5) double bond of 56 with 
subsequent acetylation of the free hydroxyl group gave compound 57 
Neighboring group assisted opening of the epoxide in the presence of boron 
trifluoride etherate, followed by an aqueous workup gave a 1.1 mixture of the 
C(5) and C(6) monoacetates Treatment of the mixture with methanolic 
hydrogen chloride gave (+)-aspicilin in 22% overall yield from [S]-
methyloxirane 53 
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In 1997 Chênevert et al.20 presented an enzymatic app roach to the synthesis 
of the C(3)-C(9) f ragment of (-)-aspicilin (scheme 1.12). 
The ketotriol 59 was ob ta ined by reaction of d ihydroxyacetone phosphate 
with the a ldehyde 58, in the presence of fructose 1,6-diphosphate aldolase 
fo l lowed by in situ hydrolysis of the intermediate phosphate ester with ac id 
phosphatase. 
он о 
Bncr ^ ^ XHO * Л -^— r-VS 
58 о ' ОН 
°ч_, ° OBn ОН ОН 
59 
О ОМЕМ 
Ь,с 
о о—\ 
* Г 4 г ^ ° d-' • Г-^fS 
ОВп / О ОВп / О С ОАс 
60 61 
a. (i) Dihydroxyacetone phosphate (DHAP), fructose l,6-diphosphate (FDP) aldolase; 
(ii) acid phosphatase, 42%; b. NaBH(OAc)3, HOAc, 60%; с DMP, PPTS, CH2CI2, 86%; d. 
DOWEX 50W-X8, MeOH, 60%; e. AcCI, 2,4,6-collidine, CH2CI2, 90%; f. MEMCI, DIPEA, 
CH2CI2, 87%. 
Scheme 1.12 
After reduction of the keto function of 59, the resultant tetrahydroxy 
c o m p o u n d was t r e a t e d with 2,2-dimethoxypropane in the presence of 
pyridinium p-toluenesulfonate to form the d i a c e t o n i d e 60. Selective 
deprotect ion fo l lowed by selective acetylat ion a n d subsequent conversion 
of the free hydroxy g r o u p into the corresponding 2-methoxyethoxymethyl 
ether g a v e c o m p o u n d 61 which was identical with the intermediate which 
Solladié et al?6 (scheme 1.6) used to accomplish the synthesis of (-)-aspicilin. 
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1.2 Aim and outline of this study 
The aim of this study was to use an appropriate carbohydrate as the chiral 
source for the introduction of the three hydroxy groups at C(4), C(5) and C(6) 
in the target molecule (+)-aspicilin. Two principle approaches, viz. 
macrolactonization of the corresponding secolactone, and olefination as 
the essential step in the formation of the macrocycle, will be described. 
In chapter 2 the approach involving lactonization as the ultimate step is 
reported. It will be shown that D-mannose can be converted into the 
required dialdehyde intermediate and that this "Chiron" will be the basis for 
the total synthesis of (+)-aspicilin. Two Wittig type coupling reactions will lead 
to the hydroxy acid needed to perform the lactonization under modified 
Yamaguchi conditions. 
The "olefination" approach will be described in chapter 3. This strategy makes 
use of the same "Chiron" as described in chapter 2. An intramolecular Wittig 
reaction was attempted as an ultimate ring-closure reaction. 
The synthesis of smaller ring analogues of aspicilin is reported in chapter 4. 
Again, the same chiral synthon derived from D-mannose was used. Changing 
the aliphatic phosphonium salt in one of the two Wittig reactions, an 11-
membered ring analogue of aspicilin could be synthesized. 
Summaries in English and Dutch conclude this thesis. 
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CHAPTER 
TOTAL SYNTHESIS OF (+)-ASPICIUN FROM MANNOSE VIA AN 
ULTIMATE YAMAGUCHI LACTONIZATION 
2.1 Introduction 
S everal syntheses of the macrolide aspicilin 1 have been reported in recent years and are outlined in the introductory chapter. In this chapter a total synthesis of 1 will be described using a suitable 
monosaccharide derivative as a chiral building block for the introduction of 
21 
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the three hydroxyl groups at C(4), C(5) and C(6) with the correct 
stereochemistry. 
In the retrosynthetic analysis of aspicilin the ring closure via lactonization is 
chosen as the ultimate step. The required iecocompound, viz. the 17-
hydroxy-a.ß-unsaturated acid shown in scheme 2.1, can be obtained via a 
Wittig type coupling between С (7) and С (8) and a subsequent 
hydrogénation reaction. For the introduction of the unsaturated carboxylic 
acid unit, i.e. C(l)-C(3), a Wittig type reaction also seems appropriate. In this 
retrosynthetic approach a "dialdehyde", as shown in the box in scheme 2.1, is 
an essential intermediate. 
Differentiation between both aldehyde functions can be achieved via a 
regiospecific furanoside A with appropriate protecting functions. The 
furanoside A, which has the D-/Kxo-configuration can be derived from D-
mannose using simple protecting functions1 and a glycol cleavage reaction.2 
Alternatively, the formal "dialdehyde" intermediate can also be obtained 
from a protected D-arabinose derivative,3 whereby the С(5) hydroxyl group 
serves as a latent aldehyde group (scheme 2.1 ). 
The long-chain fragment В can be built up by chain elongation using 
protected 3-hydroxy-l-iodobutane as the source for chirality at C(17). This 
chiral hydroxy halide can be obtained from ethyl acetoacetate through a 
yeast reduction of the prochiral keto function as the key step4 (scheme 2.1 ). 
In chapter 3 an alternative route for the total synthesis of aspicilin will be 
discussed, involving ring closure of the macrocycle by means of a Wittig-type 
olefination reaction, i.e. closure by formation of the C(2)-C(3) double bond.5 It 
will then be shown that the same intermediate A plays a key role in this 
alternative approach. 
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Scheme 2.1 
The choice of appropriate protecting groups in the various steps of the total 
sequence is of crucial Importance for an effective synthesis. An Illustrative 
example Is the preparation of the 17-hydroxy carboxyllc acid required for the 
ultimate lactonization reaction. To obtain this iecolactone, i.e. the 
intermediate with the carboxylic acid and the C(17) alcohol group 
unprotected, both functions must be selectively deprotected leaving the 
protecting functions at C(4), C(5) and C(6) Intact. Furthermore, the ester 
function and the C(17) protection must be compatible with the synthetic 
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operations during the preparation of the respective building blocks. In 
multistep syntheses subtle reaction conditions often need to be applied to 
achieve the required chemospecificity for protection and deprotection. The 
total synthesis of aspicilin is no exception to this rule, as will be seen later. 
2.2 Synthesis of the carbohydrate-derived building block 
D-Arabinose was initially considered as the best starting material with the 
required stereochemistry. The aldehyde function was converted into a bis-
thioacetal by a reaction with n-butanethiol6 to give compound 2 (scheme 
2.2). Selective monotritylation of the primary hydroxy group followed by 
acetylation of the remaining, secondary hydroxy groups gave the fully 
protected arabinose derivative 3. 
OH BuS OH BuS OAc OAc 
Ï a I ? b 1 ? с ? 
О ^ т OH »" B u S ^ V ' ^ r ' T I H *- B u S ' ^ f ^ f O T r *" O ^ T J Oïï 
ОН ОН ОН ОН ÖAc OAc ÔAc OAc 
D-arabinose 2 3 4 
a. л-BuSH, HCl, 91%; b. PhaCCI. pyridine, followed by АсгО, 85%; с. HgCb/HgO, 
acetone/hhO, 50%. 
Scheme 2.2 
Hydrolysis of the dithioacetal function of 3 to the required aldehyde 4 was 
attempted by treatment with mercuric chloride - mercuric oxide.6 Impure 
aldehyde 4 was obtained but in a disappointing yield of 50%. This was caused, 
presumably, by trimerization of the aldehyde produced and further studies in 
this direction were abandoned. 
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In view of the above discouraging result, it was found necessary to investigate 
the second route, depicted in the retrosynthetic analysis (scheme 2.1), using 
D-mannose as starting material for further studies. 
Treatment of D-mannose with 2,2-dimethoxypropane in the presence of a 
catalytic amount of SnCl2 gave what was expected to be the 
thermodynamically favoured 2,3:5,6-di-C4sopropylidene-a-D-mannofuranose 
5 (scheme 2.3).7 Treatment of this product 5 with benzyl bromide and sodium 
hydride in DMF8 gave the benzyl glycoside as a mixture of the a and β 
anomers, 6a and 6b, respectively, in an approximate ratio of 4:1. 
0„ ^O 0 0 0^ Ό 
λ λ X 
6a (a-anomer) 6b (ß-anomer) 
a. DMP, acetone, SnCI2, 76%; NaH, BnBr, DMF, 71% 6a and 18% 6b. 
Scheme 2.3 
The formation of the ß-glycoside 6b in 20 - 40% yield may be explained by the 
fact that the oxygen atoms of the acetal groups could function as a crown-
ether like system9 under the reaction conditions (i.e. sodium hydride/benzyl 
bromide in DMF). The anomeric hydroxyl would react with sodium hydride and 
could be held partially in the normally unfavourable b-configuration through 
the coordination effect of both acetal groups (figure 2.1). In this manner, 
reaction with benzyl bromide would lead to compound 6b, the ß-glycoside. It 
is of interest to note that in a earlier study on the methylation of compound 5 
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under similar conditions an anomeric mixture of a and β methyl glycoside in a 
ratio of α:β = 1:10 was reported.10 In the present case the lower proportion of 
the β compound could be due to the bulkiness of the benzyl group 
compared with the methyl group. Addition of 18-crown-6 could direct the 
reaction to yield predominantly the a-anomer.' The anomeric configurations 
of the glycosides 6a and 6b are not critical to the overall synthesis described 
in this chapter. The removal of the aglycons at a later stage would yield the 
same type intermediate from either anomer or mixtures thereof [vide infra). 
The use of one pure anomer e.g. 6a was considered necessary for ease of 
physical characterization of ensuing compounds. 
Figure 2.1 
Apart from the desired a-D-product 6a, and the expected by-product 6b, a 
third product X was observed to be present. Chemical shifts derived from the 
13C-NMR spectrum showed that this material contained a 1,3-dioxolane ring 
c/5-fused to a pyranoid ring (acetal carbon at δ 111.0), and a 1,3-dioxane ring 
[acetal carbon at δ 99.6 and a large Δδ (10.1) between the two methyl 
carbons on this acetal carbon].1 1 
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Subsequent studies12 have shown that treatment of D-mannose with benzyl 
alcohol/BF3.Et20 gives mainly the benzyl a-D-mannopyranoside containing ca 
8% of the ß-anomer. Treatment of the foregoing anomeric mixture with 2,2-
dimethoxy-propane in the presence of ¿otoluenesulfonic acid gave the 
benzyl 2,3:4,6-di-Oisopropylidene α-D and ß-D-pyranosides 8a and 8b 
(scheme 2.4). Both the iH-NMR and 13C-NMR spectra of the ß-anomer 8b 
were in full agreement with the spectrum of the unknown by-product X of the 
aforementioned benzylation reaction performed to produce 6a. (scheme 
2.3). 
o—» o—« 
b >< > o >< V o 
*- Ом-i >-"OBn + On-i У-С OBn 
D-mannose 7a,b 8a (a-anomer) 8b (ß-anomer, 
a . BnOH, BF3.Et20,%: b. DMP, TosOH, 82% 8a a n d 8% 8b. 
Scheme 2.4 
The di-isopropylidene pyranose derivative observed here was formed as the 
kinetically controlled product during the reaction of D-mannose with 2,2-
dimethoxypropane in the presence of SnCb. This gave the unfavoured ЬевгуІ 
ß-D-glycoside X (which is compound 8b) upon treatment with sodium 
hydride/benzyl bromide in DMF (scheme 2.3). The preferential formation of β-
glycosides of D-mannose is unusual because of the axial disposition of the 
C(2)-hydroxy group. When however, C(l) in D-mannose is converted into the 
glycoside 7a,b, the pyranoside ring is retained in the subsequent 
isopropylidination reaction (scheme 2.4). 
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Table 2. /.Physical data of compounds 6a/b and8a/bi2 
-fhtr- ^S>£p ^ Ъ - *££}-
0 0 0 0 0 0 0 0 
л л л л 
6а 6Ь 8а 8Ь 
α vs. β 
6а 
8а 
6Ь 
8Ь 
[а)2о° 
+ 77.1 а 
+ 18.5 b 
- 3 7 . 6 а 
- 94.2 а 
Rf c 
-0.50 
-0.55 
-0.30 
-0.40 
Н-С(1)(6) 
5.08 (singlet) 
5.11 (singlet) 
4.91 (doublet) 
4.94 (doublet) 
furano vs. pyrano 
6а 
6b 
8а 
8b 
1 3 C acetáis (δ) d 
109.2/112.8 
109.1/113.7 
99.6/109.4 
99.6/111.0 
1 3
С Д М е ( 5 ) d 
2.3 
1.9 
10.2 
10.1 
а. с = 1.0 (CH2CI2); b. с = 1.1 (CHCI3); с EtOAc/Hexane = 1:2; d. CDCI3 
The differences in stability of the isopropylidene groups in compound 6a is well 
known. It is possible to remove the exocyclic 5,6-acetal group selectively by 
treatment with 80% aqueous acetic acid to give compound 9 in good yield. 
The resultant diol 9 is easily oxidized by sodium metaperiodate with concurrent 
removal of one carbon atom (glycol cleavage) to furnish the corresponding 
C-5 aldehydo derivative 10.'3 
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•fHc HO-HO4 
o o o o o o 
Л Д А 
6α 9 10 
α. 80% aqueous acetic acid, 96%; b. NalCu. acetone/water, 92%. 
Scheme 2.5 
This aldehyde 10 essentially constitutes the key intermediate A shown in the 
retrosynthetic scheme (scheme 2.1 ). 
In the synthetic plan the aldehydo function in 10 should undergo a Wittig-
type olefination reaction to introduce the long carbon chain C(8)-C(l8) using 
fragment В (see scheme 2.1) as the Wittig reagent. This olefination reaction 
was first tested with a simpler Wittig-type reagent, viz. triethyl phosphono-
acetate, in a Horner-Wadsworth-Emmons reaction (scheme 2.6).u 
o o о о о о 
Л А Д 
10 11 12 
a. Triethyl phosphonoacetate, DIPEA, LiCI, acetonitrile, 99%; b.H2, Pd-C, EtOH, 91%. 
Scheme 2.6 
Compound 11 was obtained in good yield and subsequent catalytic 
hydrogénation of 11 (palladized charcoal) yielded the i-erythro lactol 12. It is 
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important to note that during the hydrogénat ion of the unsaturated ester the 
benzyl ag lycon was also hydrogenolysed. 
The lactol 12 is the model compound for the a t tachmen t of the unsaturated 
ester [C(l)-C(2)] unit via a Wlttig-type condensat ion with a phosphorus ylid, or 
a phosphonate anion (scheme 2.7). The react ion of lactol 12 with tnethyl 
phosphonoaceta te did not p roceed Treatment of 12 with ethoxycarbonyl-
triphenyl phosphonlum bromide did not yield the expec ted 13 but gave 
compound 14 as a l: l mixture of the a and β anomers. C o m p o u n d 14 arises, 
presumably, via a Michael-type ring closure (Moffatt C-glycosidation)1 5 which 
is faci l i tated by at ta inment of a stabilized 5,5 bicyclic ring system , 6 No specific 
attempts w e r e m a d e to trap the intermediate product 13, a l though this 
w o u l d have b e e n e x p e c t e d to b e possible by a n appropr iate protect ion of 
the hydroxyl function (see section 2.4) 
"-" о 
I 
X o v .o 
Wittig 
conditions 
13 (not isolated) 
Wittig/Horner 
conditions 
X 
χ 
o . . o 
14 
a. Tnethyl phosphonoacetate DIPEA, LiCI, СНзСЫ; b Carbethoxymethylene 
tnphenylphosphorane, ChbCN, 61%. 
Scheme 2 7 
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2.3 Synthesis of the long chain fragment В 
The synthesis of the other required fragment В was achieved from 2-propyn-l-
ol 15. Treatment of 15 with L1NH2 in liquid ammonia caused deprotonation, 
and addition of л-butyl bromide gave the C-alkylated product 16 in 95% 
yield. No O-alkylation was found to occur presumably due to the greater 
stability of the Li-O-bond.17 
HO'—=—
H
 *- HO'' = ^ ^ " ^ »~ н о ^ ч ^ / ^ ' 
15 16 17 
a. IJNH2. С1Н9ВГ, ІМНз(І), 95%; b. KNH(CH2)3NH2. NH3(I). 66%. 
Scheme 2.8 
Application of "Brown's" acetylene zipper,'6 i.e. the potassium salt of 1,3-
diamino propane, led to migration of the triple bond to the terminal position 
to give the acetylene 17 (scheme 2.8). Compound 17 was then treated with 
ÜNH2 and the anion generated was reacted with the chiral iodide 23 to give 
partially protected alkyndiol 24 (scheme 2.10). The iodide 23 was obtained as 
depicted in Scheme 2.9. Bakers' yeast induced reduction of the prochiral keto 
function of ethyl acetoacetate 18 gave ethyl (J}-3-hydroxy butyrate 19," the 
hydroxyl group of which was protected as a Ì -ethoxyethyl ether by treatment 
with ethyl vinyl ether-pyridinium p-toluenesulfonate to give 20. Reduction of 
20 with ÜAIH4 gave the protected butanediol derivative 21, which was 
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t reated with /O-toluenesulfonyl chloride in the usual manner to give the 
sulfonate 22. Reaction of 22 with sodium iodide in a c e t o n e (Finkelstein 
reaction) then g a v e c o m p o u n d 23. 
o o a НО О b E E Q ° с 
OEt ' ^-^ ^OEt ' — OEt 
18 19 20 
EEQ d EEQ
 e EEO 
23 
a. Bakers' yeast, 98%; b. Ethyl vinyl ether, PPTS, CH2CI2, 99%; с UAIhU, Et20, 99%; d. 
TosCI, pyridine, 76%; e. Nal, Си, acetone, 70%. 
Scheme 2.9 
It was found necessary to use the iodide 23 in the base-mediated coupl ing 
with 17, since tosylate 22, a n d the bromide a n a l o g u e of 23 failed to react 
under the same conditions. The temperature of the react ion was also f o u n d 
to b e important. A satisfactory yield of 24 was o b t a i n e d only w h e n the 
reaction mixture was maintained at -40°C (scheme 2.10). During the 
transformation of the propynol 15 to c o m p o u n d 24, protect ion of the hydroxyl 
function was not required, a n d direct formation of the tosylate 25 was 
possible. Treatment of the tosylate 25 with sodium iodide in a c e t o n e g a v e the 
iodide 26. It should b e ment ioned here that the protect ing function for the 
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C(17) OH group, viz. the 1-ethoxyethyl group, ensures easy removal in the 
stage when the 17-hydroxy carboxylic acid is required for the ultimate 
lactonization step. 
27 
a. ÜNH2, 23, NH3(I), 62%; b. TosCI, pyridine, CH2CI2, 98%; с Nal, Си, acetone, 85%; d. 
PPhs, acetonitrile, 89%. 
Scheme 2.10 
2.4 Ring closure 
The iodide 26 was reacted with triphenylphosphine in the usual manner, and 
the phosphonium salt 27 formed (scheme 2.10) was deprotonated and 
reacted with the dialdose fragment 10 (scheme 2.II). The ¿//-ratio of the 
resulting product 28 could not be determined from the ]H NMR spectral data, 
but an excess of the /-isomer would have been expected. This geometry is 
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not of importance because the double bond will be removed in the 
subsequent step. 
OEE 
27 
2_^  ^^=_^\/^-Q 
О ~ D OEE Π 
•тг : - у 
у 
0 _ ù 10 
30 OTBDPhS 
a. л-BuLi, 10, THF, 50%; b.(¡) H2, Pd(C), EtOAc; (ii) Na, ЫНз(І), 73%; с. (i) Allyloxycarbonyl 
methylenetriphenylphosphorane, CH2CI2, (ii) TBDPhSiCI, imidazole, 78%. 
Scheme 2.1J 
Catalytic hydrogénation of 28 in the presence of palladized charcoal (5%) 
gave only the fully saturated product without cleavage of the benzyl 
protecting function. Occasionally a change of solvent can result in 
hydrogenolysis,19 but in the present case this was not achieved and it was 
necessary to treat compound 28 with sodium in liquid ammonia to cause 
satisfactory debenzylation. Both a and β isomers of lactol 29 could be used in 
the Wittig reaction with allyloxycarbonylmethylenetriphenylphosphorane to 
give a preponderance oF the £-a,ß-unsaturated ester. The ylid was prepared 
in a manner similar to that described for the corresponding ethyl derivative.20 
The resulting hydroxy-alkene esters readily underwent a Michael-type 
reaction, vide supra, to yield the C-glycosides of 36 (as a 1:1 a/ß-mixture) 
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depicted in scheme 2.12. It was considered essential to protect the resulting 
hydroxyl group in situ\n order to prevent further intramolecular reaction. 
OEE OEE 
a. allyloxycarbonylmethylenetriphenylphosphorane, CH2CI2, 84%. 
Scheme 2.12 
The /e^-butyldiphenylsilyl group (TBDPhS) was used for this purpose, since it is 
less acid-labile than its dimethyl analogue21. The latter was found to migrate 
partly from the C4-OH to the C17-OH under the mild acidic conditions that 
were eventually necessary to remove the 1-ethoxyethyl protecting group 
from C(17). At this point it should be mentioned that choosing the allylic ester 
in the Wittig reagent is of great importance in connection with its selective 
removal to form the free carboxylic acid required for the lactonization step. 
The corresponding ethyl ester could not be removed under sufficiently mild 
conditions. The allyl ester can be hydrolyzed simply in a very mild and 
selective manner. 
This series of observations is a clear demonstration of the need of a careful 
choice of appropriate protecting groups for the respective functions. An 
inappropriate choice in the beginning of a sequence may manifest itself in a 
highly undesired manner later on. The choice of the ester moiety is a clear 
example thereof. 
A free hydroxy acid is required to perform a Yamaguchi macrolactonization.22 
Treatment of 30 with МдВгг caused removal of the 1-ethoxyethyl group and 
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subsequent t reatment of 31 with morpholine a n d (РпзРЦРсІ as catalyst 
r e m o v e d the allylic ester protect ion to give the required free ac id 32.2 3 
f ^ O E E о 
с 
oX 
OTBDPhS 
J O E E l 
30 
i ^ O H О 
OTBDPhS 
31 
f l D H о 
32 OTBDPhS 
Yamaguchi 
a. MgBr2, Et20, 82%; b. (PPh3)<Pd, morpholine, THF, 69%; с. 2,6-Dichlorobenzoyl 
chloride, Е(зЫ, THF, followed by DMAP, Δ, toluene, 53%. 
Scheme 2.13 
In the normal Yamaguchi procedure, 2 2 2,4,6-trichlorobenzoyl chloride is used 
to make a mixed anhydride with a carboxylic a c i d . This reagent is quite 
expensive a n d therefore the less expensive 2,6-dichlorobenzoyl chloride was 
used with c o m p o u n d 32 to p r o d u c e 33 in satisfactory yields.24 It h a d b e e n 
shown previously24-25 that 2,6- a n d 2,5-dichlorobenzoyl chloride w e r e equally 
effect ive in the Yamaguchi methodology. Lactonization was a c h i e v e d by 
treatment of the anhydride of 32 a n d 2,6-dichlorobenzoic ac id with DMAP. 
The proton on C(17) in c o m p o u n d 33 was situated at c o 5 p p m in the iH-NMR 
spectrum of the product a n d is characteristic of these types of macrolides. 
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a TBAF THF b TFA/НгО/МеОН (15 14) 68% 
Scheme 2 14 
The lactone 33 requires deprotect ion of the a c e t a l function a n d the silyl 
group to give the target c o m p o u n d 1 (scheme 2 14) The tert-
butyldiphenylsilyl g r o u p in c o m p o u n d 33 was resistant to acidic hydrolysis, a n d 
normal F~ ion c l e a v a g e , even at e l e v a t e d temperature It was found, 
however that t reatment of 33 with tnfluoroacetic a c i d in aqueous m e t h a n o l 
to remove the isopropylidene blocking group r e m o v e d the silyl funct ion 
simultaneously to give 1 directly in g o o d yield (68%) In this manner the total 
synthesis of aspicihn 1 was c o m p l e t e d in a 3% overall yield starting from D-
mannose The melting point, opt ical rotation a n d iH-NMR spectrum (400 MHz) 
of the crystalline (EtOAc/hexane) product w e r e consistent with literature 
va lues 2 4 2 B 
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During the course of this work Quinkert et al. 2 9 reported a tota l synthesis of (+)-
aspicilin, also based on D-mannose as starting material which was c o n v e r t e d 
Into a l d e h y d e 10 (scheme 2.15). However, they found that a l d e h y d e 10 
r e a c t e d with phosphonium salt 37 t o give 38 in quite low yield (<20%). This 
product 38 resembles c o m p o u n d 28 In scheme 2.11. A n o t a b l e d i f ference Is 
that these authors chose an a c e t a t e function as the protect ing group for the 
C( l7) hydroxyl funct ion. An alternative route was a d o p t e d b e c a u s e of this 
low yield. Diol 9 was c o n v e r t e d into the homologous a l d e h y d e 39 in four 
steps (scheme 2.15). 
..rtOBn 
О О 0 0 Br Р Ь з Р ' - ^ Л ^ 
Л А 37 
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^Ч^ч^О 
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...ιΟΒη 
39 
a. NaICU, a c e t o n e / w a t e r ; b. 37. л-BuLi, TMEDA, toluene,<20%: с. MsCI, Et3N, CH2CI2. 
93%; d . Nal. butan-2-one, 94%; e. 9-BBN, THF; 3N NaOH, 30% H2O2, 98%; f. Oxalyl 
chlor ide, DMSO, CH2CI2; EtsN, 93%, g . 40, />BuLI, TMEDA, to luene, 92%. 
Scheme 2.15 
Phosphonium salt 40 was o b t a i n e d by convert ing l-bromo-7-
tetrahydropyranyloxy-heptane 42 into a Grignard reagent a n d react ing it 
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with (J)-methyloxirane to introduce the C(17) chiral hydroxy group (scheme 
2.16). 
42 / A 43 40 
\* 
a. Mg, (¿l-methyloxirane, THF, 94%; b. PPTS, MeOH, 91%; с CBr4, PPh3, 88%; d. PPh3, 
MeCN, 97%. 
Scheme 2.16 
Removal of the tetrahydropyranyl group from compound 43 followed by 
treatment of the resultant diol with tetrabromomethane and 
triphenylphosphine gave the primary bromide selectively which was 
converted into the phosphonium salt 40. 
Protection of the hydroxy group of compound 41 with an acetyl group, 
followed by catalytic hydrogénation to remove the benzyl group gave the 
hemiacetal 44. The α,β-unsaturated ester moiety was introduced by 
treatment of 44 with ethoxycarbonylmethylenetriphenylphosphorane in a 
Wittig-type reaction (scheme 2.17). In this reaction the intermediate hydroxyl 
function, which could cause an intramolecular Michael addition, was 
protected by a (2-methoxyethoxy)-methyl (MEM) group. 
A notable difference with the strategy followed in this thesis is the choice of 
the protecting functions for the C(l7) hydroxyl and the unsaturated 
carboxylic acid. Quinkert et a/.29 chose an acetate at C(l7) whereas in 
scheme 2.11 an 1-ethoxyethyl group was used. In our strategy an acetate at 
C(17) would have caused difficulties as it would not have been compatible 
with some of the synthetic operations shown in scheme 2.10 and 2.11. The 
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difficulties with the ethyl ester have already b e e n c o m m e n t e d u p o n during 
the discussions of the schemes 2.12 a n d 2.13. 
OH OAc 
45 46 1 
a. Ac 2 0, DMAP, CH2CI2, 99%; b. 10% Pd/C, H2. MeOH/AcOEt, 97%; с Ethoxycarbonyl-
methylenetriphenylphosphorane, toluene, 80%; d. MEM-NEt3
+CI\ MeCN, 93%; е. KOH, 
ЕЮН, H2O, 67%; f. Et3N, THF, 2,4,6-trichlorobenzoyl chloride, then pyrrolidinopyridine, 
toluene, 85%; g. TFA/MeOH/H20, 60%. 
Scheme 2.17 
The Yamaguchi 2 2 procedure was also used by Quinkert et a/.29 t o e f f e c t ring 
closure of the hydroxy a c i d 46 to give the corresponding lactone. The seco-
lactone was o b t a i n e d by a d o u b l e deprotect ion at C( l 7) a n d C( l ) using KOH 
in ethanol . Final d e p r o t e c t i o n of the C(4), C(5) a n d C(6) hydroxyl group 
protect ing functions g a v e (+)-aspicilin 1 in a 13% overall yield starting from D-
mannose. 
Another possible m e t h o d to synthesise (+)-aspicilin 1 was through product 36, 
obta ined during the intramolecular Michael react ion in the Wittig 
condensat ion (scheme 2.12). Under the reaction conditions used, a 1:1 ratio 
of 36a a n d 36b was o b t a i n e d , if the hydroxyl group was not t r e a t e d 
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immediately with /etf-butyldiphenylsilyl chloride (scheme 2.18). The t w o 
anomers p r o d u c e d w e r e easily separable by c o l u m n c h r o m a t o g r a p h y . 
Performing the same sequence of reactions on b o t h 36a a n d 36b, i.e. 
formation of the hydroxy acids 47a a n d 47b fo l lowed by direct ring closure 
using the Yamaguchi lactonization procedure g a v e the "Michael-macrolides" 
48a and 48b, respectively. 
29 
47 a,b 
l ^ ^ - ^ X ^ ^ O E E 
WW' 
36 a,b 
ΌΑΙΙ 
48 a,b 
a. Allyloxycarbonylmethylenetriphenylphosphorane, CH2CI2, 41% 36a and 43% 36b; 
b. (i) MgBr2, Et20; (ii) (PPhs^Pd, morpholine, THF; с. 2,6-Dichlorobenzoyl chloride, Et3N, 
THF, followed by DMAP, Δ, toluene, 23% 48a and 37 % 48b (steps b+c). 
Scheme 2.18 
Since the t w o a n n e l a t e d f ive-membered rings are the stabilizing factor in 48a 
a n d 48b, it s e e m e d obvious to r e m o v e the isopropylidene groups first, a n d 
then perform a retro-Michael r e a c t i o n 3 0 3 2 to obta in the target m o l e c u l e (+)-
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aspicilin 1. When this sequence was attempted with compound 48b, a 
different lactone 49b, was obtained on treatment with trifluoroacetic acid-
methanol-water (scheme 2.19). The formation of product 49b from 48b can 
readily be explained by invoking an initial hydrolysis of the isopropylidene unit 
to give a C(4)-C(5) diol, which then undergoes an intramolecular trans-
esterification reaction of the macrocyclic lactone function, thereby liberating 
the C(17) hydroxyl group. In the intermediate substituted furan derivative the 
C(4) hydroxyl is apparently favourably positioned with respect to the lactone 
unit, thus facilitating the observed trans-esterification. 
г о 
Г^°Л он 
49b 
48b 
a. TFA/MeOH/hhO. 78%. 
Scheme 2.19 
In view of this result, the retro Michael reaction was performed first by 
treatment of 48a and 48b with LDA (scheme 2.20). These reactions were 
carried out only on a 1-2 mg scale. Although opening of the furan ring was 
achieved and a double bond with an f-configuration was formed, the 
product was not the expected isopropylidene-protected aspicilin. The 
product appeared to be the non-cyclized hydroxy acid 50 (scheme 2.20) 
which was probably produced by traces of water in the reaction mixture. 
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f^OH о 
- CjiCCx 
OH 
48 а. Ь 
50 
a. LDA/THF, 49%. 
Scheme 2.20 
On a larger scale, where the presence of water can be excluded more 
rigorously, this route could be more promising. Lack of material and time 
precluded further studies in this direction. 
2.5 Discussion 
The rewarding result of the work described in this chapter is that a total 
synthesis of (+)-aspicilin 1 has been completed successfully using D-mannose 
as the starting material for the introduction of the hydroxyl groups at С(4), 
C(5) and C(6) with the correct absolute stereochemistry. One of the key steps 
is the synthesis of intermediate A (see scheme 2.1) with appropriate 
protecting functions. It was demonstrated that compound 10 (scheme 2.5) 
could serve as such. The second essential step is the removal of the benzyl 
group after attachment of the long chain fragment to C(7) (scheme 2.11). 
Originally it was planned that during the hydrogénation of the triple and 
double bond in 28 (scheme 2.12) the benzyl group would be removed 
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concurrently. For reasons that are not understood, the removal of the benzyl 
group did not take place. Recourse to the reductive removal of the benzyl 
group using sodium dissolved in liquid ammonia overcame this obstacle. It is 
of interest to note that Quinkert et at? did apparently not encounter any 
difficulty with the removal of the benzyl protecting group in their intermediate 
41 (scheme 2.17). In the present study several hydrogenolytic conditions were 
attempted, therefore, the remarkable difference between compounds 28 
and 41 is probably attributable to subtle structural effects. The third essential 
feature of the total synthesis is the choice of the protecting functions at C(l 7), 
and the carboxylic acid group (C(l)). The selected combination of an 
ethoxyethyl group at C(l7) and an allyl ester at C(l) allowed their smooth 
removal in both cases to produce the required 5ecolactone. In this context 
the choice of the /etf-butyldiphenylsilyl group for the protection of the С(6) 
hydroxyl group turned out to be of crucial importance. The fourth essential 
reaction involves the Wittig-Horner olefination for the introduction of the α,β-
unsaturated ester unit (scheme 2.II) with an in situ protection of the C(6) 
hydroxyl group to avoid the intramolecular Michael addition which would 
have otherwise taken place (scheme 2.12). 
Quinkert et al.29 were unable to perform a satisfactory chain elongation with 
key intermediate 10. In the present study this coupling was achieved in a yield 
of 50% which was found to be acceptable (scheme 2.11 ). They also reported 
an alternative approach for the conversion of key intermediate 10 into 
compound 38 (scheme 2.15), viz. the use of a condensation of 10 with an 
appropriate Cn-phenyl sulfone in a so-called Julia reaction. The secondary 
alcohol in this Cn-fragment was protected with a /e/T-butyldimethylsilyl group. 
The hydroxy sulfone thus obtained was subjected to a reductive elimination 
reaction employing lithium in liquid ammonia thereby furnishing product 38 
with a /etf-butyldimethylsilyl group instead of an acetate function in a yield of 
44 
Total synthesis of (+j-aspicilin... 
51% (calculated on 10). It should be noted that this analogue of 38 could be 
debenzylated upon hydrogenolysls in propan-2-ol with Pd(C) as the catalyst. 
In retrospect, it is unfortunate that the synthetic plan based on the use of D-
arabinose as Chiron had to be relinquished because of difficulties with 
aldehyde 4 (scheme 2.2). Elaboration of the potential of this intermediate was 
not pursued further for this reason. Application of a protecting function other 
than acetate, e.g. the ethoxyethyl group would have merited further 
investigation. 
The opening of the "Michael macrocyclic lactone" 48 (scheme 2.18) has not 
yet met with success, however, a more detailed study seems warranted. 
2.6 Experimental 
General methods : ]H NMR spectra were recorded on a Varian EM 390 (90 
MHz, CW), a Bruker AC-100 (l 00 MHz, FT), a Bruker WM-200 (200 MHz, FT) or a 
Bruker AM-400 (400 MHz, FT) spectrometer with Me4Si or CDCI3 as internal 
standards. l 3 C NMR spectra were recorded on a Bruker AC-lOO (25 MHz, FT) or 
a Bruker AM-400 (100 MHz, FT) spectrometer with CDCI3 as the internal 
standard. IR spectra were recorded on a Perkin-Elmer 298 
spectrophotometer. For mass spectroscopy a double focusing VG 7070E 
spectrometer was used. Melting points were determined on a Reichert 
Thermopan microscope and are uncorrected. Optical rotations were 
measured in the solvents indicated using a Perkin-Elmer 241 automatic 
Polarimeter. Thin-layer chromatography (TLC) was performed using silica gel 
plates (F-254, Merck). Compounds were visualized with a UV lamp, 3% H2SO4 
in ЕЮН/140 °C or O.l M К2СГ2О7 / Ι M H2S04 (20:1). Flash-column 
chromatography was performed using silica gel 60H (Merck) at a pressure of 
1.5 bar in the solvent mixtures indicated. GLC was conducted with a Hewlett-
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Packard HP 5790A or HP 5890 gas Chromatograph, using a capillary HP cross-
linked silicone column (25 m χ 0.31 mm) connected to a HP 3390 or HP 5890 
calculating integrator. 
Dichloromethane and acetonitrile were distilled from P2O5, petroleum ether 
and hexane were distilled from СаНг, diethyl ether was pre-dried over СаСІг 
and distilled from NaH, toluene was distilled from Na, THF was distilled from 
LÌAIH4 and pyridine and triethylamine were distilled from KOH. 
2,3:5,6-Di-0-isopropylidene-a-o-mannofuranose5 : D-mannose (50 g, 0.28 mol) 
was treated with a mixture of 2,2-dimethoxypropane (120 ml, 0.98 mol) and 
acetone (150 ml, 2.0 mol) in the presence of SnCl2 (50 mg, 0.26 mmol) in a 
prescribed manner7 to give 5 (56.5 g, 76%). M.p. 122 °C (cyclohexane). [а]о° = 
+ 16.5° (c=1.0. CH2CI2). 'H-NMR (100 MHz, CDCI3): δ 5.37 (d, IH, J (H-C(l), OH) = 
2.6 Hz, H-C(l)); 4.82 (dd, IH, J (H-C(3), H-C(2)) = 5.8, J (H-C(3), H-C(4)) = 3.5, H-
C(3)); 4.60 (d, 1 H, J (H-C(2). H-C(3)) = 5.8, H-C(2)); 4.38 (dt, 1 H, J (H-C(5), H-C(4)J 
= 7.0, J (H-C(5), H-C(6J) = 5.3, H-C(5)); 4.17 (dd, IH, J (H-C(4), H-C(3)) = 3.5, J (H-
C(4), H-C(5)) = 7.0, H-C(4)); 4.07 (d, 2H, J (H-C(6), H-C(5)J = 5.3 Hz, H2-C(6)); 3.27 
(d, IH, J (OH, H-C(l)) = 2.6 Hz, OH; 1.46 (s, 6H, C(CH3)2); 1.38 (s, 3H, CH3); 1.33 (s, 
3H, CH3); IR (KBr, cm-l) : ν 3500-3340 (OH), 2980, 1380/1370 (C(CH3)2), 1070 (C-
O). 
Benzyl 2,3:5,6-di-0-isopropylidene-a-0-mannofuranoside 6a : Compound 5 
(20.0 g, 76.9 mmol) was slowly added portionwise to a stirred suspension of 
sodium hydride (2.2 g, 92 mmol) in anhydrous DMF. On completion of the 
addition the mixture was treated dropwise over 4h with a solution of benzyl 
bromide (15.7 g, 91.8 mmol) in dry DMF (40 ml). At the end of the addition the 
mixture was heated at 70 °C for 1 h, cooled, treated with a mixture of ether 
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(400 ml) and water (3 χ 200 ml) and the separated organic layer dried 
(MgSCU) and concentrated in vacuo to yield a yellow syrup Traces of benzyl 
bromide were removed in vacuo at a lower pressure Column 
chromatography (hexane/EtOAc 6 1) of the residue gave first benzyl 2,3 5 6-
di-O-isopropylidene-a-o-mannofuranosideSa (19 2 g, 71 %),m.p 54°C [a]2° = 
+77 1°(c=l 1,CH2CI2) Spectral data of 6a ^H-NMR (100 MHz, CDCI3) 5 7 37-
7 25 (m 5H arom ), 5 08 (s 1 H, H-C(l)) 4 80 (dd, IH J (H-C(3). H-C(2)) = 5 9, J 
(H C(3), Η C(4)) = 3 4, H-C(3)) 4 68-4 33 (m 4H H-C(2)+H-C(5)+ H2C-Ph), 4 20-
3 91 (m 3H H-C(4)+H2-C(6)), 1 46 (s, 6H, C(CH3)2), 1 39 (s, 3H, CH3), 1.32 (s, 3H, 
CH3), IR(KBr cm-i) ν 3020 (arom CH) 2930 1380/1370 (C(CH3)2) 1070 (C-O) 
Further elution gave benzyl 2 3 4 6-di-O /sopropyl/dene-ß-o-mannopyranoside 
8b (1 08g, 4%), m ρ 76 80°C [a]g°= 94 2°(c=102 CH2CI2) ^H-NMR (100 MHz, 
CDCI3) δ 7 41-7 28 (m, 5H arom), 4 94 (d, IH J (PhCH2, PhCH2) = 13 0, 
PhCH2)) 4 78 (d IH J (H-C(l) H-C(2)) = 2 8, H-C(l)), 4 70 (d, IH, J (PhCH2, 
PhCH2) = 13 0 PhCH2)), 4 27-3 65 (m 5H H-C(2)+H-C(3)+H-C(4)+H2-C(6)), 3 22 
(m IH, H-C(5)), 1 57 (s 3H, CH3) 1 49 (s, 3H CH3) 1 41 (s, 3H, CH3). 1 36 (s, 3H, 
CH3), 13C-NMR (100 MHz, CDCI3) 136 82 (s C{/pso-Ph)) 128 46 (d, 2C(/J7-PhJ), 
128 1 7 (d 2C(oPh)), 127 97 (d, C(/>Ph)), 11101 (s, C(2 3-O-isoprop )), 99 60 (s, 
C(4,6 O-isoprop)), 96 62 (d C(1)) 76 34 (d) 74 54 (d) 72 09 (d), 70 27 (t, CH2-
Ph) 65 89 (d) 62 47 (t) 28 98 (q, CH3(4,6-0-isoprop )), 27 68 (q, CH3(2,3-0-
isoprop)) 26 05 (q, CH3(2,3-C4soprop )) 18 84 (q, СH3(4,6-O-isoprop )), 
followed by benzyl 2 3 56-di-O-isopropylidene-ß-O-mannofuranoside 6b (4 84 
g, 18%) [a]2°= -37 6° (c=0 92 CH2CI2) 'H-NMR (400 MHz, CDCI3) δ 7 39-7 26 
(m 5H, arom), 4 91 (d IH J (PhCH2, PhCH2) = 12 4 PhCH2)), 4 75 (d, IH, J (H-
C(l) H-C(2))=37 H-C(l)) 4 70(dd IH J (H-C(3) H-C(2)J = 6 1, J (H-C(3) H-
C(4)) =4 0, H-C(3)) 4 67 (d 1 H, J (PhCH2, PhCH2) = 12 4, PhCH2)), 4 58 (dd, 1 H, 
J (H C(2) H-C(l))=37 J (H-C(2) H-C(3)) = 6 1 H-C(2)), 4 46 (dt IH, J(H-C(5) 
H C(4)J = 7 7, J (H-C(5), H-C(6)) = 5 3, H-C(5)), 4 09 (d, 2H, J (H-C(6), H-C(5)) = 
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5.3, H2-C(6)); 3.59 (dd, IH, J (H-C(4), Н-С(З)) = 4.0, J (Н-С(4), Н-С(5)) = 7.7, Н-
С(4)); 1.56 (s, ЗН, СН3); 1.44 (s, ЗН, СН3); 1.38 (s, ЗН, СН3); 1.36 (s, ЗН, СН3); 1 3С-
NMR (100 MHz, CDCI3): 137 16 (s, C(/pjoPh)); 128.34 (d, 2C(m-Ph)); 127.98 
(d,2C(oPh)); 127.80 (d, C(p-Ph)); 113.65 (s, C(2,3-C4soprop.)); 109.12 (s, C(5,6-
CMsoprop.)); 101.23 (d, C(l)); 79.73 (d, C(2)); 79.08 (d, C(3)); 77.10 (d, C(4)); 
73.29 (d, C(5)); 71.39 (t, CH2-Ph); 66.77 (t, C(6)); 26.96 (q, CH3(2,3-C4soprop.)); 
25.69 (q, CH3(5,6-a¡soprop.)); 25.26 (q, CH3(5,6-CMsoprop.)); 25.08 (q, CH3(2,3-
O-isoprop.)). IR (film, cm-') : ν 3020 (arom CH), 2980, 2930, 1450, 1380/1370 
(C(CH3)2), 1070 (C-O). 
Benzyl 2,3-O-isopropy/idene-a-D-mannofuranoside 9: A stirred solution of 
compound 6a (10.2 g, 29.1 mmol) in 80% aqueous acetic acid (500 ml) was 
maintained overnight at room temperature, concentrated in vacuo and 
toluene (3 χ 100 ml) distilled in vacuo from the residue to give compound 9 
(8.63 g, 27.8 mmol, 96 %) as a syrup. 'H-NMR (100 MHz, CDCI3): δ 7.37-7.25 (m, 
5H, arom.); 5.09 (s, IH, H-C(l)); 4.92 (dd, IH, J (H-C(3), H-C(2)) = 5.8, J (H-C(3), 
H-C(4)) = 3.6, H-C(3)); 4.71-4.41 (m, 3H, H-C(2) + H2C-Ph); 4.05-3.55 (m, 4H, H-
C(4)+ H-C(5) + H2-C(6)); 2.93 (bs, 2H, HO-C(5) + HO-C(6J); 1.47 (s, 3H. CH3); 1.32 
(s, 3H, CH3); IR (film, cm"1) : ν 3600-3200 (OH), 3080/3060/3030, 2980/2930, 
1380/1370 (C(CH3)2), 1080 (C-O). 
Benzyl2,3-0-isopropylidene-a-D4yxo-pentodia/do-i,4-furanoside 10 : A stirred, 
cooled (0°C) solution of glycoside 9 (7.76 g, 25.0 mmol) in acetone (50 ml) 
was treated dropwise with a solution of sodium metaperiodate (5.89 g, 27.5 
mmol) in water (50 ml) and then set aside at room temperature for l h. The 
mixture was concentrated in vacuo, the residue extracted with 
dichloromethane (50 ml) and the organic extract dried (MgSO.4) and 
concentrated in vacuo to give compound 10 (6.37 g, 22.9 mmol, 92 %), m.p. 
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53°C. iH-NMR (90 MHz, CDCI3): δ 9.60 (d, IH, J (H-C(5). H-C(4)) = 1.1 H-C(5)); 
7.24 (s, 5H, arom.); 5.24 (s, IH, H-C(l)); 5.05 (dd, IH, J (H-C(3), H-C(2)) = J (H-
C(3). H-C(4)) = 5.7, H-C(3)); 4.76-4.30 (m, 4H, H-C(2)+H-C(4)+H2C-Ph); 1.42 (s, 
3H, CH3); 1.27 (s, 3H, CH3); IR (KBr, cm"1) : ν 3030 (arom CH), 
2980/2930/2875/2830, 1735 (C=0). 1375 (C(CH3)2), 1270/1210, 1090 (C-O). 1 3C-
NMR (100 MHz, CDCI3): 197.65 (d, C(5)); 136.79 (s, C(ipso-Ph)); 128.51 (d, 2C(m-
Ph)); 128.07 (d,2C(oPh)); 128.04 (d, C(p-Ph)); 113.46 (s, C(2,3-0-isoprop.)); 
105.84 (d, C(l)); 84.61 (d); 84.13 (d); 80.85 (d); 69.28 (t, CH2-Ph); 25.81 (q, 
CH3(2,3-CMsoprop.)); 24.52 (q, CH3(2,3-C4soprop.)); 
(4R, 1 E/zy Benzyl 2,3-0-isopropylidene-4-(2'-ethoxycarbonyleth-1 '-eny/J-a-L-
eryihro-furanoside 11. A stirred suspension of LiCI (127 mg, 3.0 mmol) in dry 
acetonitrile (10 ml) maintained under N2 was treated with a mixture of 
triethylphosphonoacetate (673 mg, 2.9 mmol), düsopropylethylamine (323 
mg, 2.50 mmol) and the foregoing compound 10 (695 mg, 2.50 mmol) and set 
aside until analysis (TLC, hexane/EtOAc 4:1) indicated completeness of 
reaction (16 h). The mixture was treated with sufficient water to obtain 
homogenuity, concentrated partially, in vacuo, to remove acetonitrile and 
the aqueous residue extracted with ether (3 χ 20 ml). The combined extracts 
were dried (MgS04) and concentrated in vacuo to give compound 11 as a 
yellowish oil (860 mg, 2.47 mmol, 99 %), [a\f = +10.8° (c=l, CH2CI2). ^-NMR 
(90 MHz, CDCI3): δ 7.30 (s, 5H, arom.); 6.97 (dd, IH, J (H-C(6), H-C(5)) = 17.8, J 
(H-C(6), H-C(4)) = 6.2, H-C(6)): 6.13 (dd, IH. J (H-C(5), H-C(6)) = 17.8, J (H-C(5), 
H-C(4)) = 1.3, H-C(5)); 5.14 (s, IH, H-C(l)); 4.82-4.43 (m, 5H, H-C(2)+H-C(3)+H-
C(4)+ H2C-Ph); 4.20 (q, 2H, J (H-C(l'), H-C(2"J) = 7.2, H2C(1'); 1.45-1.13 (m, 9H, 3 
CH3); IR (film, cm-i) : ν 3060/3030 (arom CH), 2980/2935, 1715/1650 (C=0), 
1450, 1370 (C(CH3)2), 1265, 1090 (C-O). 
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(4R)-2,3-0-tsopropy/idene-4-f2'-ethoxycarbony/ethy/J^-i-eryihro-furanose 12. A 
solution of compound 11 (800 mg, 2.30 mmol) in ethanol (25 ml) was treated 
with palladized charcoal (5%, 200 mg), and hydrogenated (I atm) until 
analysis (TLC, hexane/EtOAc) indicated complete reduction. The insoluble 
material was removed by filtration through a layer ( c o 3 mm) of "hyflo", the 
inorganic material washed with ethanol (10 ml) and the combined filtrate 
and washings concentrated in vacuo to yield 12 (544 mg, 2.09 mmol, 91 %) as 
a colourless oil. iH-NMR (90 MHz, CDCI3): δ 5.29 (s, IH, H-C(l)): 4.73-4.46 (m, 2H, 
Н-С(2) + Н-С(З); 4.38-3.97 (m, ЗН, Н-С(4) + H2C(ester); 2.43 (t, 2Н, J (Н-С(б'), Н-
С(5)) = 7.4, Н2С(6); 1.97 (dt, 2Н, J (Н-С(5), H-C(6J) = 7.3, J (Н-С(5), H-C(4)J = 7.2, 
Н2С(5); 1.52-1.10 (m, 9Н, 3 СН3); IR (film, crrr') : ν 3600-3100 (OH), 2980/2935, 
1730 (C=0), 1445, 1370 (C(CH3)2). Ю95 (C-O). 
Ethoxycarbonylmethyltriphenylphosphonium bromide. A solution of 
triphenylphosphine (1.31 g, 5.0 mmol) and ethyl bromoacetate (0.79 g, 5.0 
mmol) in toluene (10 ml) was heated under reflux and the reaction was 
monitored by TLC. After completion, the suspension was cooled to room 
temperature. The precipitated salt was isolated by filtration and washed with 
petroleum ether. After drying the target compound was obtained as an off-
white solid (1.88 g, 90%), m.p. 158°C. 'H-NMR (90 MHz, CDCI3): δ 8.05-7.46 (m, 
15H, arom.); 5.60 (d, 2H, J (H2C, P) = 14.1, H2C-P; 4.05 (q, 2H, J H2C, H3C = 7.3, 
CH2; 1.08 (s, 3H, J H3C, H2C = 7.2, CH3); 
Ethyl (3a'S,4'R.6a'Rj-3-(6'-ethoxycarbonylmethyl-2',2'-dimethyl-tetrahydro-
furo[3.4-d][l,3] dioxol-4'-yl)-propionate 14. A stirred solution of compound 12 
(260 mg, l.O mmol) in dry acetonitrile (10 ml) maintained under N2 was 
treated with carbethoxymethylenetriphenylphosphorane (700 mg, 2.0 mmol) 
and then heated under reflux for I8h. The cooled mixture was concentrated 
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in vacuo and flash column chromatography (hexane/EtOAc 7:1) gave 
compound 14 (201 mg, 0.61 mmol, 61%). Ή-NMR (200 MHz, CDCI3): δ 4.78-4.30 
(m, 3Η, H-C(3a')+H-C(6')+H-C(6a')); 4.13 and 4.09 (2q, 2H, J (H3C-//2C-O. HjZ-
H2C-O = 7.3, H3C-//2C-O; 3.85 (m, IH, H-C(4'a)); 3.46 (ddd, IH, J (H-C(4'ß), H-
C(3)) = J (H-C(4'ß), H-C(3)) = 6.6, J (H-C(4'ß), Н-С(За')) = 3.0, H-C(4'ß)); 2.73 (d, 
IH, J (H-C(l"ß), Н-С(б')) = 6.6, Н-С(Г'Р)): 2.53-2.34 (m, ЗН, Н2-С(2)+Н-С(1"а)); 
2.05 (m, 2Н, Н2-С(3)); 1.53-1.16 (m, 12Н, 4 СН3); IR (film, cm"1) : ν 
2980/2930/2870, 1725 (C=0), 1445, 1370 (C(CH3)2), 1260, 1095 (C-O). 
Hept-2-yn-l-ol 16. Liquid ammonia [ca 250 ml) maintained at -80°C, and 
under N2, was treated with a small piece of clean lithium metal (со 100 mg) 
whereon the mixture turned blue. Lithium metal (6.2 g, 0.90 mol) was then 
added carefully to the stirred mixture which turned into a gray suspension 
after ca 20 min. The stirred suspension was treated with a solution of prop-2-
yn-l-ol (25.2 g, 0.45 mol) in dry THF (30 ml) over 15 min, set aside for 1.5h and 
then treated dropwise over lh with 1-bromobutane (20.5 g, 0.15 mol) in dry 
THF (25 ml). Analysis (GLC) after a further 1.5h indicated no unreacted 1-
bromobutane. The ammonia was allowed to evaporate at room temperature 
and the residue was treated with a mixture of ether (200 ml) and water (200 
ml), the aqueous layer extracted with ether (3 χ 50 ml) and the combined 
ether layers washed with water (200 ml), dried (MgSCU) and concentrated in 
vacuo to yield 16 (15.5 g, 0.14 mol, 93 %) as a colourless oil. ^-NMR (100 MHz, 
CDCI3): 5 4.19 (bs, 2H, H2C(l));2.78(bs, IH, OH); 2.25-2.04 (m, 2H, H2C(4)); 1.61-
1.29 (m, 4H, H2C(5)+ H2C(6)); 0.90 (t, 3H, J (H-C(7), H-C(6)) = 6.2, H3C(7)); IR 
(film, cm-1) : ν 3600-3200 (OH), 2200/2300 (C=C. alkyne). 
Hept-6-yn-l-ol 17. Liquid ammonia (250 ml) maintained at -80°C and under 
nitrogen was treated with potassium metal (16.3 g, 0.42 mol), added in small 
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pieces After ca 30 mm the original clear dark blue solution became a gray 
suspension whereon it was treated with 1,3-diaminopropane (350 ml) to give 
a black suspension, which was stirred for 30 mm and then warmed to ca 50°C 
in vacuo to evaporate residual ammonia The black suspension was heated 
(80°C) and treated with a solution of compound 16 (14 5 g, 0 13 mol) in dry 
THF (50 ml), set aside until analysis (GLC) indicated completeness of reaction 
(ca2h), and poured onto ice (300 g) The mixture was extracted with ether (3 
χ 50 ml) and the combined ether layers washed with water (200 ml), dried 
(MgSCU), concentrated in vacuo and distillation (38°C/0 2 mm Hg) of the 
residue gave compound 17 (9 63 g, 86 mmol 66%) as a colourless oil ïH-NMR 
(lOOMHz, CDCI3) 5 3 64 (t, 2H J (H-C(l), H-C(2)) = 6 0, H2C(l )), 2 31-2 10 (m, 2H, 
H2C(5)), 2 04-1 87 (m, 2H, H-C(7)+ OH) after addition of D2O l 94 (t, IH, J (H-
C(7), H-C(5)) = 2 9, H-C(7)), l 74-1 44 (m, 6H, H2C(2)+ H2C(3)+ H2C(4)), IR (film, 
cm"1) ν 3600-3200 (OH), 2120 (C=C, alkyne) 
Ethyl ßj-3-hydroxybutanoate 19 Compound 19 was obtained by Bakers' 
yeast mediated reduction of ethyl acetoacetate in the manner described4 
[a]2°=+30 3° (c=l,CH2CI2) е е 66% iH-NMR (100 MHz, CDCI3) 6 4 16-3 98 (m 
3H, H-C(3) + Н2С(Г), 347 (bs, IH, OH) 2 32 (d, 2H, J (H-C(2), H-C(3)) = 6 0, 
H2C(2)), 1 35-1 07 (m 6H H3C(2)+ H3C(4)), IR (film, cm-') ν 3600-3100 (OH) 
2970/2930, 1725/1700, 1450, 1380, 1070 (С O) 
Ethyl ßJ-3-fl' ethoxy-ethoxyjbutanoate 20 A stirred, cooled (0°C) solution of 
compound 19 (23.0 g 174 mmol) in dry dichloromethane (200 ml) containing 
pyndinium p-toluenesulfonate (80 mg) was treated with ethyl vinyl ether (18 g 
250 mmol) and set aside for lh The mixture was treated with saturated 
aqueous sodium hydrogen carbonate solution (50 ml) and the separated 
aqueous layer was extracted with dichloromethane (2 χ 50 ml) The 
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combined organic extracts were washed with water (50 ml), dried (MgS04) 
and concentrated in vacuo to give compound 20 (35.3 g, 173 mmol, 99%) as 
an oil. [a]2°= +5.5° (c=l .22, CH2CI2). 'H-NMR (100 MHz, CDCI3): δ 4.76 (q, IH, J 
(H-C(T'), H-C(2")) = 5.3, H-C(l")); 4.28-3.95 (m, 3H, H-C(3) + H2C(1'); 3.79-3.25 
(m, 2H, H2C(1'"); 2.72-2.18 (m, 2H, H2C(2)); 1.37-1.05 (m, 12H, H3C(2') + H3C(2") + 
H3C(2"') + H3C(4)); IR (film, cm-i):v 2975/2920, 1725, 1440, 1380 1070 (C-O). 
ßJ-3-l' l'-Ethoxy-ethoxy)butan-ì'-0121. A stirred suspension of LÌAIH4 (5.59 g, 147 
mmol) in dry ether (250 ml) was treated carefully with a solution of compound 
20 (34.7 g, 170 mmol) in dry ether (250 ml). Analysis (GLC) after an additional 
2h indicated complete reduction, whereon the mixture was cooled (0°C), 
treated sequentially with water (6 ml), 15% aqueous KOH solution (6 ml), water 
(12 ml), and solid MgSCU (20 g). Inorganic material was removed by filtration, 
washed with warm ether (100 ml) and the combined filtrate and washings 
concentrated in vacuolo give compound 21 (27.4 g, 169 mmol, 99%), [a]p° = 
+41.0° (c=1.03, CH2CI2). !H-NMR (100 MHz, CDCI3): δ 4.72 and 4.70 (2q, 
together IH, J (Н-С(Г), H-C(2')) = 5.3, Н-С(Г)); 4.08-3.37 (m, 6H, H2C(1) + Н-С(З) 
+ Н2С(1") + ОН; 1.83-1.55 (m, 2Н, Н2С(2)); 1.28-1.04 (m, 9Н, Н3С(2') + Н3С(2") + 
Н3С(4)); IR (film, cm"1): ν 3600-3100 (OH), 2970/2930, 1440, 1375, 1330, 1080 (C-
O). 
ß)-3-(i '-Ethoxy-ethoxyJ-l-p-to/uenesu/fonytoxy-butane 22. Compound 21 (27.0 
g, 167 mmol) was treated with ¿otoluenesulfonyl chloride (35.0 g, 184 mmol) in 
the usual manner to give tosylate 21 (39.9 g, 126 mmol, 76%), [a]p°= +13.4° 
(c=1.04, CH2CI2). 'H-NMR (100 MHz, CDCI3): δ 7.79 (d, 2H, J (o-H-Ph, m-H-Pb) = 
8.4, 2 o-H-Ph)); 7.32 (d, 2H, J (m-H-Ph, o-H-Ph) = 8.4, 2 m-H-Ph)); 4.70 and 4.57 
(2q, together 1 H, J (H-C(l'), H-C(2')J = 5.5, H-C(l')); 4.25-3.28 (m, 5H, H2C(1 ) + H-
C(3) + Н2С(Г); 2.42 (s. 3H, H3C-Ph); 1.90-1.65 (m, 2H, Н2С(2)); 1.35-1.07 (m, 9Н, 
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НзС(2') + H3C(2") + Н3С(4)); IR (film, cm"1): ν 2970/2930. 1595, 1440, 1380, 1355, 
1175, 1070,995. 
ß)-3-(l'-Ethoxy-ethoxy)-l-iodo-butane 23. A stirred solution of the foregoing 
sulfonate 22 (39.5 g, 125 mmol) in dry acetone (250 ml ) was treated with 
copper turnings and sodium iodide (30.0 g, 200 mmol) and the mixture 
heated under reflux in the absence of light for 12h. An additional amount of 
sodium iodide (20.0 g, 133 mmol) was then added and boiling was continued 
for a further 24h. The inorganic material was collected by filtration, washed 
with acetone (100 ml), and the combined filtrate and washings concentrated 
in vacuo. The residue was treated with water (100 ml) and ether (100 ml) and 
the separated aqueous layer extracted with ether (3 χ 50 ml). The combined 
ether layers were washed successively with saturated aqueous sodium 
thiosulfate solution (100 ml), water (100 ml), dried (MgSCU) and concentrated 
in vacuo to yield 23 (23.8 g, 87.5 mmol, 70%) as an oil. 'H-NMR (100 MHz, 
CDCI3/D2O):5 4.70(q, 1 H, J (H-C(l'), H-C(2')) = 5.3, H-C(l')); 4.04-3.39 (m, 3H, H-
C(3) + H2C(1");3.23 (t, 2H, J (H-C(l), H-C(2)) = 6.7, H2C(1); 1.91 (m. 2H, H2C(2)); 
1.43-1.10 (m, 9H, H3C(2') + H3C(2") + H3C(4)); IR (film, crrH): ν 2980/2930, 1450, 
1370, 1120. 
ß)-10-(l'-Ethoxy-ethoxy)-undec-6-yn-l-ol2A. Lithium metal (350 mg, 50 mmol) 
was added in small pieces to stirred, cooled (-80°C) liquid ammonia 
maintained under nitrogen and, after a period of 30 min, compound 17 (2.80 
g, 25.0 mmol) was added to the gray suspension which was then set aside for 
30 min. The mixture was then allowed to attain a temperature of -40°C 
whereon it was treated dropwise with a solution of the iodide 23 (6.80 g, 25.0 
mmol) in dry THF (25 ml) over 15 min and set aside for 18 h when analysis 
(GLC) indicated the absence of unreacted compound 23. The mixture was 
concentrated in vacuo ano the residue treated with water (100 ml) and ether 
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(100 ml). The separated aqueous layer was extracted with ether (3 χ 50 ml) 
and the combined ether layers were dried (МдБОд) and concentrated in 
vacuo. Flash column chromatography (cyclohexane/DME 4:1) of the 
resultant crude material yielded 24 (3.94 g, 15.4 mmol, 62%). 'H-NMR (100 MHz, 
CDCI3):ô4.75and4.72(2q, together IH. J (H-C(l'), H-C(2')) = 5.3, Н-С(Г)); 3.94-
3.42 (m, 5Н, Н2С(1) + Н-С(Ю) + Н2С(Г); 2.38-2.01 (m, 4Н, Н2С(5) + Н2С(8)); 1.89 
(bs, 1 H, ОН); 1.74-1.07 (m, 17Н, Н2С(2) + Н2С(3) + Н2С(4) + Н2С(9) + Н3С(11 ) + 
Н3С(2') + Н3С(2")); IR (film, cm-') : ν 3600-3150 (OH), 2940/2850, 1450, 1370, 
1120. MS (Cl+):m/e= 257 (M++1,0.003%), 241 (-CH4, 12%), 211 (-EtOH,31%), 167 
(-ethoxy ethanol, 6%), 73 (CH3CH2OCHCH3+, 100%), 45 (CH3CHOH+, 68%). 
ß)-10-(r-Ethoxy-ethoxy)-l-p-toluenesulfonyloxy-undec-6-yne 25. Treatment of 
compound 24 (5.00 g, 19.5 mmol) with p-toluenesulfonyl chloride (4.10 g, 21.5 
mmol) in pyrldlne/dlchloromethane and processing ¡η the usual manner gave 
the sulfonate 25 (7.84 g, 19.1 mmol, 98%). 'H-NMR (100 MHz, CDCI3): δ 7.78 (d, 
2H, J (o-H-Ph, m-H-Ph) = 8.3, 2 o-H-Ph)); 7.35 (d, 2H, J (m-H-Ph, oH-Ph) = 8.1, 2 
m-H-Ph)); 4.75 and 4.70 (2q, together IH, J (H-C(l'), H-C(2')) = 5.2, H-C(l')); 4.02 
(t, 2H, J (H-C(l), H-C(2)) = 6.2, H2C(1)); 3.92-3.30 (m, 3H, H-C(10) + H2C(1"); 2.45 
(s, 3H, H3C(Tos)); 2.38-1.95 (m, 4H, H2C(5) + H2C(8)); 1.89 -1.06(m, 17H, H2C(2) + 
H2C(3) + H2C(4) + H2C(9) + H3C(11) + H3C(2') + H3C(2")); IR (film, cm-') : ν 
2970/2930/2860, 1440, 1370/1330, 1120, 1070,970. 
ßj-10-(l'-Ethoxy-ethoxy)-l-iodo-undec-6-yne2S. The tosylate 25 (7.40 g, 18.0 
mmol) In acetone (200 ml) was treated with copper turnings and sodium 
iodide (3.75 g, 25.0 mmol) as described earlier for compound 23 [vide supra) 
to yield 26 (5.61 g, 15.3 mmol, 85%). 'H-NMR (100 MHz, CDCI3): δ 4.75 and 4.70 
(2q, together IH, J (Н-С(Г), H-C(2')) = 5.1, H-C(l')); 4.04-3.38 (m, 3H, H-C(10) + 
H2C(1");3.18 (t, 2H, J (H-C(l), H-C(2)) = 6.8, H2C(1 )); 2.38-2.03 (m, 4H, H2C(5) + 
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H2C(8)), 1 98 -1 08(m, 17H. H2C(2) + H2C(3) + Н2С(4) + Н2С(9) + Н3С{11) + 
НзС(2') + Н3С(2")). 
ßJ-10-(l'-Ethoxy-ethoxy)-undec-6-yn-l-yl-tnphenylphosphonium iodide 27 А 
stirred mixture of the iodide 26 (5 26 g, 14 4 mmol) and tnphenylphosphme 
(5.24 g, 20.0 mmol) in dry acetone (50 ml) was heated under reflux for 48 h, 
concentrated in vacuo and the residual foam was dissolved in a minimum 
amount of dry acetonitnle (1 ml) and washed with dry ether (50 ml) The ether 
was decanted and the residue was concentrated in vacuo This procedure 
was repeated, until no Р1пзР/Р1пзР=0 was detectable in the ether washings, 
whereon concentration in vacuo gave compound 27 (8.00 g, 12.7 mmol, 
89%) as an off-white foam. 'H-NMR (100 MHz, CDCI3) δ 7 79-7 61 (m, 15H, Ph3); 
4.73-4,60 (m, IH, Н-С(Г)), 3 90-3 30 (m, 5Н, Н2С(1) + Н-С(Ю) + Н2С(Г); 2 28-
2 02 (m, 4Н, Н2С(5) + Н2С(8)), 1 92-1 38 (m, 8Н, Н2С(2) + Н2С(3) + Н2С(4) + 
Н2С(9) ; 1 31-1 08 (m, 9Н, Н3С(11) + Н3С(2') + Н3С(2')), IR (film, cm') . ν 3050, 
2950/2920/2850, 1585, 1470/1435 (P-Ar), 1110, 995 
f4R, IISJ Έ/IJ Benzyl 2,3-0-isopropylidene-4-[l I '-(I "-ethoxyethoxy)-dodec-1 '-
en-7'-yn-l-y/J-a-i.-ery\hro-furanos/de 28 BuLi (16 M in hexare, 3 4 ml, 5 5 
mmol) was added dropwise to a stirred, cooled (0°C) solution of the salt 27 
(3 14 g, 5 00 mmol) in dry THF (150 ml), which caused a change of colour from 
pale yellow to dark orange The mixture was set aside for 15 mm whereon it 
was treated dropwise with a solution of glycoside 10 (1 39 g, 5 00 mmol) in dry 
THF (150 ml) and set aside for 15 mm The mixture was treated with saturated 
aqueous NH4CI solution (100 ml), extracted with ether (3 χ 50 ml), the 
combined organic layers washed with water (100 ml), dried (MgSCU) and 
concentrated in vacuo to give compound 28 (1 26 g, 2 52 mmol, 50 %) ]H-
NMR (100 MHz, CDCI3) δ 7 33 (s, 5H arom ), 581-5 56 (m, 2H, Н-С(Г)+Н-С(2') 
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5.10 (s, IH, H-C(l)); 4.86-4.43 (m, 6H. Н-С(2)+Н-С(3)+Н-С(4)+Н-С(Г')+Н2С-Р(і); 
3.92-3.32 (m, ЗН, Н-С(П') + Н2С(Г"); 2.35-2.06 (m, 6Н, Н2С(3')+ Н2С(6') + 
Н2С(9')); 1.80-1.05 (m, 21 H, Н2С(4') + Н2С(5') + Н2С(10') + 2 Н3С(і-ргор.), 
Н3С(12') + Н3С(2") + НзС(2'")); IR (film, cm') : ν 3030 (arom СИ), 2960/2930, 
2860, 1450, 1370 (С(СН3)2), 1205, 1160, 1080 (С-О). 
/4R, / / %)-2,3-0-lsopropylidene-[l 1 '-(1 "-ethoxyethoxyj-dodec- /-y//-£4.-erythro-
furanose 29 : A solution of compound 28 (500 mg, 1.00 mmol) in ethyl acetate 
(50 ml) was treated with palladized charcoal (5%, 300 mg) and hydrogenated 
(1 atm) until analysis (TLC, hexane/EtOAc 4:1) indicated completeness of 
reaction. The insoluble material was removed by filtration through "hyflo" (co 5 
mm), washed with ethyl acetate (25 ml) and the combined filtrate and 
washings concentrated in vacuo. A solution of the residue in dry THF (25 ml) 
was added with stirring to liquid ammonia (50 ml) maintained at -80°C under 
nitrogen. On completion of the addition the mixture was treated with small 
pieces of sodium metal until a permanent blue colouration was produced. 
The mixture was set aside at room temperature to allow evaporation of 
excess ammonia, the residue treated with ether (50 ml), water (50 ml), the 
organic layer dried (MgSC>4) and concentrated in vacuo to give compound 
29 (304 mg, 0.73 mmol, 73 %) as a yellowish oil. ^-NMR (100 MHz, CDCI3): δ 
5.20 (d, IH, J (H-C(l), OH) = 1.8, H-C(l)); 4.73-4.55 (m, 3H, H-C(2)+H-C(3)+H-
C(l")); 4.03 (dt, IH, J (H-C(4), H-C(3)) = 3.2, J (H-C(4), H-C(5)) = 6.3, H-C(4)); 
3.75-3.20 (m,3H, H-C(i Γ) + Н2С(Г"); 2.51 (d, IH, J (OH, H-C(l)) = 1.8, OH); 1.60-
1.05 (m, 35H, H2C(1'-10')+ 2 H3C(i-prop.), H3C(12') + H3C(2") + H3C(2'")); IR (film, 
cnrv') : ν 3620, 3400-3050 (OH), 2980/2960/2930, 2860, 1445, 1370 (C(CH3)2), 
1085 (C-O). 
Allyloxycarbonylmethyltriphenylphosphonium bromide. A solution of 
triphenylphosphine (2.62 g, 10.0 mmol) and allyl bromoacetate (1.43 g, 8.0 
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mmol) in toluene (15 ml) was heated under reflux and the reaction was 
monitored by TLC. Upon completion, the suspension was cooled to room 
temperature and the precipitated salt was isolated by filtration, washed with 
petroleum ether and dried (MgSCu) to give a yellow sticky substance (3.50 g, 
99%). !H-NMR (100 MHz, CDCI3): δ 8.01-7.71 (m, 15H, arom.); 5.85-5.46 (m, IH, 
H-C(2-allylJ); 5.60 (d, 2H, J (H2C, P) = 13.8, H2C-P); 5.27-5.06 (m, 2H, H2C(3-allyl)); 
4.47 (d, 2H, J (H2C(l-allyl), H-C(2-allyl)) = 5.7, H2C(l-allyl)); 
Allyl (2c,4R,5SM, 17SJ-17-(1 '-Ethoxy-ethoxy)-6-[^eú-butyl)diphenylsilyloxy]-4,5-
(¡sopropylidenedioxy)-octadec-2-enoate 30. A stirred mixture of compound 29 
(120 mg, 0.288 mmol) and allyloxycarbonyl-methyltriphenylphosphorane (311 
mg, 0.865 mmol) in dry dichloromethane (20 ml) was set aside at room 
temperature until analysis (TLC, hexane/EtOAc 4:1) indicated complete 
consumption of 29 (ca4h). The mixture was then treated with imidazole (45 
mg, 0.661 mmol) and Abutyldiphenylsilyl chloride (158 mg, 0.576 mmol), set 
aside until analysis (TLC, hexane/EtOAc 4:1 ) indicated completion of reaction, 
treated with water (25 ml) and the separated aqueous layer extracted with 
dichloromethane (30 ml). The combined dichloromethane layers were dried 
(MgSCU), concentrated in vacuo and column chromatography 
(hexane/EtOAc 5:1) of the crude material gave compound 30 (165 mg, 0.224 
mmol, 78 %).1H-NMR (100 MHz, CDCI3): δ 7.79-7.67 (m, 4H, rn-Ph); 7.41-7.26 (m, 
6H, oPh + p-Ph); 6.75 (dd, IH, J (H-C(3), H-C{2)) = 15.7, J (H-C(3), H-C(4)) = 6.6, 
H-C(3)); 6.18-5.71 (m, 2H, H-C(2)+H-C(2-allyl)); 5.45-5.13 (m, 3H, H2C(3-allyl)+H-
C(l')); 4.89-4.46 (m, 4H, H2C(l-allyl)+H-C(4)+H-C(5)); 4.35-4.08 (m, IH, H-C(6)); 
3.81-3.39 (m, 3H, H-C(17) + H2C(1"); 1.51-1.01 (m, 35H, H2C(7-16)+ 2 H3C(i-
prop.), H3C(18) + H3C(2') + H3C(2")); 1.07 (s, 9H, /-butyl); 
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Ally/ {2E,4R.5$.OR, 17SJ- 17-Hydroxy-6-[fiert-butyl)diphenylsilyloxy]-4,5-
(isopropylidenedioxy)-octadec-2-enoate 31. A stirred solution of compound 
30 (30.8 mg, 41.8 μηηοΙ) in dry ether (10 ml) was treated with 1 ml of a solution 
of МдВгг [prepared by reacting Mg (85 mg) with 1,2-dibromoethane (0.65 g) 
in dry ether (5 ml)] and set aside overnight at room temperature. The mixture 
was treated with water (5 ml) and the separated water layer extracted with 
ether ( 2 x 5 ml). The combined ether layers were dried (MgSCu) and 
concentrated in vacuo to give 31 (22.8 mg, 34.3 μηηοΙ, 82 %). Ή-NMR (ЮО 
MHz, CDCI3): δ 7.71-7.53 (m, 4H, m-Ph); 7.36-7.20 (m, 6H, o-Ph + p-Ph); 6.69 (dd, 
l H, J (H-C(3), H-C(2)) = 15.6, J (H-C(3), H-C(4)) = 6.7, H-C(3)J; 6.06-5.68 (m, 2H, H-
C(2)+H-C(2-allyl)); 5.34-5.10 (m, 2H, H2C(3-allyl)); 4.60-4.46 (m, 4H, H2C(l-
allyl)+H-C(4)+H-C(5)); 4.24-4.09 (m, IH, H-C(6)); 3.83-3.50 (m, 2H, H-C(l7) + OH); 
l .41-LOI (m, 29H, H2C(7-16)+ 2 H3C(i-prop.) + H3C(18); 0.98 (s, 9H, /-butyl). 
f2E,4R,5S,6R, 17SJ- 17-Hydroxy-6-[fiert-butyl)diphenylsilyloxy]-4,5-
(isopropylidenedioxy)-octadec-2-enoic acid 32. A stirred solution of the 
foregoing material in dry, oxygen-free THF (10 ml) was treated with (PPh3)4Pd 
(3.93 mg, 3.43 μΐηοΙ) and morpholine (29 μΙ, 343 μΐηοΙ) and set aside at room 
temperature until analysis (TLC, hexane/EtOAc 2:1 ) indicated completeness of 
reaction [ca 3h). The mixture was treated with saturated aqueous tartaric 
acid solution (5 ml) and ether (10 ml). The separated aqueous layer was 
extracted with ether (2x5 ml) and the combined ether extracts were washed 
with water (10 ml), dried (MgSCu), and concentrated in vacuo to yield 
compound 32 (14.8 mg, 23.7 μίτιοΙ, 69 %). ÏH-NMR (100 MHz, CDCI3) : δ 7.70-
7.57 (m, 4H, /ττ-Ph); 7.37-7.27 (m, 6H, oPh + p-Ph); 6.68 (dd, IH, J (H-C(3), H-
C(2)) = 15.6, J (H-C(3), H-C(4)) = 6.6, H-C(3)); 5.82 (d, IH, J (H-C(2), H-C(3)) = 
15.6, H-C(2)); 4.44 (dd, IH, J (H-C(4), H-C(3)) = 6.6, J (H-C(4), H-C(5)) = 6.1, H-
C(4)); 4.12 (dd, 1 H, J (H-C(5), H-C{4)) = 6.1, J (H-C(5), H-C(6)) =8.1. H-C(5)); 3.88-
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3.51 (m, 2H, Н-С(6) + Н-С(17)); 1.29-0.97 (m, 29Н, Н2С(7-16)+ 2 Н3С(і-ргор.) + 
H3C(18);0.97(s, 9Н, /-butyl). 
(2t^,&,6RJ7b)-6-[fteú-Butyl)diphenylsilyloxy]-4,5-(¡sopropylidenedioxy)-octa-
dec-2-en-17-olide 33. A stirred solution of the hydroxy acid 32 (14.8 mg, 23.7 
μίτιοΙ) in dry THF (5 ml) containing Methylamine (4.0 ml, 33.6 цтоі) maintained 
under argon was treated with 2,6-dichlorobenzoyl chloride (4.5 ml, 33.6 μίτιοΙ) 
and set aside at room temperature for 2 h. At the end of this period the 
precipitated ET3N.HCI was removed by filtration, the filtrate diluted with dry 
toluene (25 ml) and added dropwise over 2.5h to a boiling solution of DMAP 
(22 mg, 185 μίτιοΙ) in toluene (5 ml). The mixture was heated for a further lh, 
set aside overnight at room temperature, diluted with ether (50 ml), washed 
with saturated aqueous tartaric acid solution (25 ml), saturated aqueous 
sodium hydrogen carbonate solution (25 ml), water (25 ml) and the organic 
layer was dried (MgS04> and concentrated in vacuo. Column 
chromatography (hexane/EtOAc 5:1) of the residue gave compound 33 (7.6 
mg, 12.5μπιοΙ, 53%). Ή-NMR (100 MHz, CDCI3/D2O): δ 7.77-7.63 (m, 4Η, m-Ph); 
7.40-7.30 (m, 6H, σ-Ph + />Ph); 6.59 (dd, 1 H, J (H-C(3), H-C(2)) = 15.5, J (H-C(3), 
H-C(4)) = 8.6, H-C(3)); 5.83 (d, IH, J (H-C(2), H-C(3)) = 15.6, H-C(2)); 5.06 (sext., 
IH, J (H-C(17), H-C(18)) = 5.8, H-C(17)); 4.43 (dd, IH, J (H-C(4), H-C(3)) = 8.6, J 
(H-C(4), H-C(5)) = 5.9, H-C(4)); 4.11 (dd, 1 H, J (H-C(5), H-C(4)) = 5.9, J (H-C(5), H-
C(6)) = 8.1, H-C(5)); 3.88-3.51 (m, 2H, (H-C(6)); 1.61-0.90 (m, 29H, H2C(7-16)+ 2 
H3C(i-prop.) + H3C(18); 1.04 (s, 9H, /-butyl). 
(+)-Aspicilin 1. A stirred solution of compound 33 (7.6 mg, 12.5 μίτιοΙ) in a 
mixture of trifluoroacetic acid-water-methanol (1:5:14, 20 ml) was maintained 
at 50°C until analysis (TLC, ) indicated the absence of starting compound 33. 
The mixture was treated with ether (25 ml), washed with saturated aqueous 
sodium hydrogencarbonate solution (25 ml) and saturated aqueous sodium 
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chloride (25 ml). The combined aqueous phases were extracted with ether 
(25 ml) and the combined ether layers were dried (MgSCu)) and 
concentrated in vacuo io give compound 1. Recrystallization (hexane/EtOAc 
4:1) yielded 2.8 mg 1 (8.5 μηηοΙ, 68 %), m.p. 154-155°C (150-152°C24, 149-
151°C25, 150°C2A, 153-154°C27, 155-157°C28. 154-156°C29, 154-156°C33, 150-
152°C34, 151.5-153°C35). [a]f= +36° (c=0.12, CHCI3) ([αβ° = -34° (c=0.85, 
CHCI3)24. [a]20= -33° (c=4.1. CHCI3)25, [a]2°= +32° (c=2.31, CHCI3)27, [a]§° = +32° 
(c=2.31, CHCI3)28, [a]20= +32° (c=2.31, CHCI3)29, [a]f= +38.5° (c=1.05. CHCI3)33. 
[α]ο°= +37.7° (c=0.22. CHCI3)34, [a£° = +39.6°(c=0.24, CHCI3)35). 'H-NMR (400 
MHz, CDCI3/D2O): δ 6.90 (dd, IH, J (H-C(3), H-C(2)) = 15.8, J (H-C(3), H-C(4)) = 
5.0, H-C(3)); 6.12 (dd, ÌH, J (H-C(2), H-C(3)) = 15.8, J (H-C(2), H-C(4)) = 1.7, H-
C(2)); 5.06 (sext., IH, J (H-C(17), H-C(18)) = 6.2, H-C(17)); 4.58 (m, IH, H-C(4)); 
3.78 (dt, IH, J (H-C(6), H-C(5)) = 2.8, J (H-C(6), H-C(7)) = 6.9, H-C(6)); 3.59 (dd, 
IH, J (H-C(5), H-C(4) = J (H-C(5), H-C(6)) = 2.8, H-C(5)); 3.15, 2.99, 2.36 (3 bs, 3 
OH); 1.58-1.20 (m, 23H, H2C(7-16)+ H3C(18). 
Allyl f3oR,4R,óR,óaS, ! ! 'SJ-fó'-fl ! "-(i '"-Ethoxyethoxy)-dodecanyl]-2',2'-di-
methyltetrahydro-furo[3,4-d][l,3] dioxol-4'-yl}-acetate 36a and allyl 
(3aR,4S,6R,6aS, i i 'SJ-fó'-fl I "-(I 'n-Ethoxyethoxy)-dodecanyl]-2,,2,-dimethyl-
tetrahydro-furo[3,4-d][L3] dioxol-4'-yl}-acetate 36b. A solution of compound 
29 (100 mg, 0.240 mmol) and allyloxycarbonylmethylenetriphenyl-
phosphorane (270 mg, 0.750 mmol) in dry dichloromethane (20 ml) was stirred 
at room temperature. The reaction was monitored by TLC (hexane/EtOAc 4:1 ) 
and was allowed to go to completion to give 36a and 36b. The mixture was 
then treated with water (10 ml) and the aqueous layer extracted with 
dichloromethane (10 ml). The combined organic layers were dried (MgSCU) 
and concentrated in vacuo to yield the crude material (123 mg). Column 
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chromatography (hexane/EtOAc 3:1) of the material gave 36a (49.0 mg, 41 
%, Rf = 0.48) and 36b (51.4 mg, 43 %, Rf = 0.41 ). 
Compound 36a: iH-NMR (100 MHz, CDCI3): δ 5.90-5.67 (m, IH, H-C(2-allyl)); 
5.34-5.10 (m, 2H, H2C(3-allyl)); 4.77-4.32 (m, ОН, H-C(3a') + H-C(4') + H-C(6a') + 
Н-С(Г") +H2C(l-allyl)); 3.81-3.26 (m, 4H, H-C(6') + H-C(l 1") + Н2С(Г"); 2.43 (d, 
2H, J (H-C(2), H-C(4')) = 7.3, H2C(2)); 1.46-0.98 (m, 35H, H2C(1"-10")+ 2 H3C-
C(2'), НзС-С(11") + H3C(2·") + H3C(2"")). 
Compound 36b: ÌH-NMR (100 MHz, CDCI3): δ 6.08-5.67 (m, IH, H-C(2-allyl)); 
5.38-5.07 (m, 2H, H2C(3-allyl)); 4.75-4.45 (m, 5H, H-C(3a') + H-C(6a') + Н-С(Г") + 
H2C(l-allyl)); 3.78 (dt, IH, J (H-C(4'), H-C(IJ) = 6.8, J (H-C(4'), H-C(3a')) = 3.3, H-
C(4')); 3.69-3.25 (m, 4H, Н-С(б') + H-C(l 1") + Н2С(Г"); 2.73 (d, 2H, J (H-C(2), H-
C(4')) = 6.8, H2C(2)); 1.55-0.95 (m, 35H, H2C(1"-10")+ 2 H3C-C(2'), H3C-C(11") + 
H3C(2'") + H3C(2"")). 
The hydroxy acids 47a and 47b, and lactones 48a and 48b were prepared 
using procedures similar to those described for compound 29. 
/7R,5S, !6R, ¡7S,2!RJ-5,19,19-Tnmethyl-4,18,20,22-tetraoxa-tricyclo[14.5.1.0'721]-
docosan-3-опе 48a: 8.2 mg (22.4 цто і , 23% over 3 steps from 36a). 'H-NMR 
(400 MHz, CDCI3): δ 5.04 (sext., 1 Η, J (H-C(5), H3C-C(5)) = 6.3, Н-С(5)); 4.61 (ddd, 
IH, J (H-C(l), H-C(2)) = 12.0, J(H-C(1), H'-C(2)) = 2.3, J (H-C(l), H-C(21)) = 1.2, H-
C(l)); 4.59 (dd, IH, J (H-C(17), H-C(21)) = 6.1, J (H-C(17), H-C(16)) = 3.6, H-
C(17)); 4.48 (dd, IH, J (H-C(21), H-C(l)) = 1.2, J (H-C(21), H-C(17)) = 6.1, H-
C(21)); 3.82 (ddd, IH, J (H-C(16), H-C(15)) = 3.6, J (H-C(16), H'-C(15)) = 9.1, J (H-
C(16), H-C(17)) =3.6, H-C(16));2.49 (dd, IH, J (H-C(2), H'-C(2)) = 15.2, J (H-C(2), 
H-C(l)) = 12.0, H-C(2)); 2.30 (dd, IH, J (H'-C(2), H-C(2)) = 15.2, J (H'-C(2), H-C(l)) 
= 2.3, H'-C(2)); 1.86-1.76 (m, IH, H'-C(15)); 1.62-1.18 (m, 28H, H-C(15) + H2C(6-
14)+2H3C-C(19), H3C-C(5)). 
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fIS,5S, ¡ÓR, ¡7S,2IRJ-5, ¡9, Ì 9-Trimethyl-4.18,20,22-tetraoxa-tricyclo[14.5.i.0l7-2lJ-
docosan-3-one 48b: 13.9 mg (37.8 μηηοΙ , 37% over 3 steps from 36a). iH-NMR 
(400 MHz, CDCI3): δ 5.04 (m, IH. H-C(5)); 4.59 (dd, IH, J (H-C(17). Н-С(21)) = 6.1, 
J (Н-С(17), Н-С(16)) = 3.6, Н-С(17)); 4.56 (dd, IH, J (Н-С(21), H-C(l)) = 3.4, J (H-
C(21), H-C(17)) = 6.1, H-C(21)); 3.91 (ddd, IH, J (H-C(l), H-C(2)) = 2.1, J (H-C(l), 
H'-C(2J) = 10.7, J (H-C(l), H-C(21)) = 3.4, H-C(l)); 3.49 (ddd, IH, J (H-C(16), H-
C{15)) = 3.1. J (H-C(16),H'-C(15)) = 9.6, J (H-C(16), H-C(17)J = 3.6, H-C(16)); 2.71 
(dd, IH, J (H'-C(2), H-C(2)) = 15.7, J (H'-C(2), H-C(l)) = 10.7, H'-C(2J); 2.58 (dd, 
IH, J (H-C(2), H'-C(2)) = 15.7, J (H-C(2), H-C(l)) = 2.1, H-C[2)J; 1.89-1.80 (m, IH, 
H'-C(15)); 1.62-1.20 (m, 28H, H-C(15) + H2C(6-14)+ 2 H3C-C(19), H3C-C(5)). 
/IS,5R,óS,7R, 11 'S J 6-Hydroxy-7-(l 1 '-hydroxydodec-Ì -yl)-4,8-dioxa-bicyclo-
[3.3.0]octan-3-one 49b: A stirred solution of compound 48b (9.8 mg, 26.6 
μίτιοΙ) in a mixture of trifluoroacetic acid-water-methanol (1:5:14, 10 ml) was 
maintained at 50°C until analysis (TLC, ) indicated the absence of starting 
compound 48b. The mixture was treated with ether (10 ml), washed with 
saturated aqueous sodium hydrogencarbonate solution (20 ml) and 
saturated aqueous sodium chloride (20 ml). The combined aqueous phases 
were extracted with ether (25 ml) and the combined ether layers were dried 
(MgSC>4)) and concentrated in vacuo to give compound 49b (6.8 mg, 20.7 
μηηοΙ. 78%). ìH-NMR (400 MHz, CDCI3/D20): δ 4.98 (dd, IH, J (H-C(5), H-C(l)) = 
J (H-C(5), H-C(6)) = 5.8, H-C(5)): 4.59 (ddd, 1 H, J (H-C(l ), H-C(2J) = 6.3, J (H-C(l ), 
H'-C(2)) = 3.0, J (H-C(l ), H-C(5)) = 6.0, H-C(l )); 4.56 (bs, 1H, J H-C(6)); 3.79 (sext., 
IH, J (H-C(ll'), H-C(12'J) = 6.0, H-C(ll')): 3.73 (ddd, IH, J (H-C(7), H-C(l')) = 
6.0, J (H-C(7), Н'-С(Г)) = 7.6, J (H-C(7), H-C(6)) = 3.9, H-C(7)); 2.79 (dd, 1 H, J (H-
C(2), H'-C(2)) = 18.7, J (H-C(2), H-C(l)) = 6.6, H-C(2)); 2.72 (dd. IH, J (H'-C(2), H-
C(2)) = 18.7, J (H'-C(2), H-C(l)) = 3.0, H'-C(2J); 1.89-1.80 (m, IH, H'-C(l')); 1.70-
1.22 (m, 19H, H2C(1'-10')); 1.19 (d, 3H, J (H-C(12'), H-C(l Г)) = 6.2, Н3С(12')). 
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/C<E,4R„5S,¿R, ì'7ъ)-6, ìV-Dihydroxy-4,5-(isopropylidenedioxy)-octadec-2-enoic 
acid 50. A solution of compound 48α,b (4.3 mg, 11.7 μίτιοΙ) ¡η dry THF (5 ml) 
was added dropwise to a stirred, cooled (-78°C) solution of LDA (14 μίτιοΙ) in 
THF (15 ml). The mixture was allowed to come to room temperature, treated 
with saturated aqueous ammonium chloride solution (5 ml) and 
dichloromethane (10 ml). The separated aqueous layer was extracted with 
dichloromethane ( 2 x 5 ml) and the combined organic layers were washed 
with water (10 ml), dried (MgSCu), and concentrated in vacuo to yield 
compound 50 (2.2 mg, 5.8 μίτιοΙ, 49 %). Ή-NMR (100 MHz, CDCI3/D2O) : δ 6.50 
(dd, IH, J (H-C(3), H-C(2)) = 12.0, J (Н-С(З), Н-С(4)) = 7.3, Н-С(З)): 5.91 (dd, IH, J 
(Н-С(2), Н-С(З)) = 15.6, J (Н-С(2), Н-С(4)) * 1, Н-С(2)); 4.40 (m, IH, Н-С(4)); 4.21-
3.63 (m, ЗН, Н-С(5) + Н-С(6) + Н-С(17)); 1.64-0.82 (m, 29Н, Н2С(7-16)+ 2 Н3С(І-
prop.) + H3C(18)). 
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CHAPTER 
ATTEMPTED SYNTHESIS OF (+)-ASPICILIN VIA A WITTIG-
TYPE RING-CLOSURE REACTION 
3.1 Introduction 
In the preceding chapter a retrosynthetic analysis of (+)-aspicilln 1 was presented based on a macrolactonization as the ultimate step. As indicated in chapter 2 an alternative approach to the synthesis of the 
macrocyclic lactone 1 would involve a ring-closure reaction by the formation 
of the C(2)-C(3) olefinic bond using a Wittig-type olefination reaction.' The 
primary secostructure derived from a retrosynthetic analysis on the basis of 
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such α Wittig-type ring-closure reaction contains a phosphorous yhd at one 
terminus and an aldehyde on the other 
Further retrosynthetic breakdown leads to two possible approaches, as is 
depicted in scheme 3 1 The proposed intermediate A can be derived from 
an appropriately protected tetrahydroxy aldehyde which in turn may be 
expected to be accessible from key structure В through a condensation 
reaction at the C(7)-aldehyde function 
B C D 
11 11 л 
D mannose D arabinose 
Scheme 3 1 
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Compound В is retrosynthetically connected to D-mannose by removal of 
one carbon atom, eg by a glycol cleavage reaction It is of interest to note 
that the key intermediate В has the same basic structure as intermediate A in 
the previous retrosynthesis which underlies the total synthesis described in 
chapter 2 
An alternative retrosynthesis of A proceeds via a suitably protected 
pentahydroxy compound which can be derived by a chain elongation of a 
protected tetrahydroxy aldehyde D In principle this species D can be 
obtained from D-arabmose 
In both retrosynthetic routes long chain fragment С will be needed for the 
projected chain elongations The synthesis of fragment С can be envisaged 
in the same manner as described in chapter 2, / e from 2-hydroxybutyrate2 as 
the chiron (see scheme 2 1 ) or alternatively from methyloxirane2 (propylene 
oxide) The latter approach is the method of choice in the planned synthetic 
sequence shown in scheme 3 1 
As already mentioned in chapter 2, the choice of the protecting functions in 
the various intermediates as well as that of the respective synthetic operations 
will determine the ultimate success of a total synthesis It will be shown that in 
the Wittig approach to the synthesis of aspicilin there is a major obstacle 
which could not be overcome 
3 2 Model reactions for the Wittig closure 
An essential feature in the retrosynthetic analysis shown in scheme 3 1 is the 
preparation of an o/cte/7ycfc>-phosphonium salt corresponding to A, since this is 
in fact the true precursor for the Wittig-type ring-closure When D-mannose is 
used as the principal chiron the aldehyde is present in a latent form as a 
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glycofuranose-derivative. In chapter 2 intermediate A (see also В in scheme 
3.1) with a benzyl glycosidic group was the key intermediate. It seems logical 
therefore, to use the same intermediate also in the synthetic plan for the 
sequence with the ultimate Wittig closure. 
Debenzylation of the benzyl glycoside is usually conveniently performed by 
hydrogenolysis. The question then arises whether a phosphonium salt is stable 
under such hydrogenolytic conditions. Therefore, a model reaction was 
designed, viz. hydrogénation of an allyloxycarbonylmethylphosphonium salt,3 
as depicted in scheme 3.2. By subjecting this phosphonium salt 2 to 
hydrogénation using palladized charcoal as the catalyst, smooth reduction of 
the allylic double bond was achieved, leaving the phosphonium salt fully 
intact. 
The second question is whether a Wittig reaction of the proposed type can 
be accomplished with a lactol such as 5 which acts as a model for the lactol 
to be used in the actual Wittig closure to obtain aspicilin. For this purpose 
phosphonium salt 3 was converted in the corresponding ylid and reacted 
with lactol 5. A mixture of £and Ζα,β-unsaturated esters 6 and 7 was obtained 
in a 60% yield. 
о
 + о + о 
^Ч^оА^РРЬзСІ *- \ ^ . 0 A ^ P P h 3 c r ÜL-*. vN^voAvSÍ.PPh3 
2 3 4 
о о О 
E t c A ^ V ^ С Е,сА--уОН О Е,сА-~ГОН 
а. Н2, Pd(C), EtOAc; b. NaOH, H2O; с. 4, CH2CI2. 
Scheme 3.2 
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Chronologically, this model experiment to test the feasibility of the Wittig 
closure, was carried out much earlier than the Wittig reaction shown in 
scheme 2.12 (chapter 2) where in a similar manner, C-glycosides4 were 
obtained during a Wittig reaction with a concurrent intramolecular Michael 
addition. Although this Moffatt-C-glycosidation5 was known, it was 
encouraging that in this case the double bond was not likewise affected. 
3.3 Synthesis of the long-chain fragment С 
In the retrosynthetic outline shown in scheme 3.1 the projected synthesis of 
fragment С involves the use of (J)-methyloxirane 8 as the source of chirality. 
This chiron contains one carbon atom less than ß-hydroxybutyrate which was 
the actual chiron used in the total synthesis described in the preceding 
chapter (see scheme 2.9). The long-chain was built-up using propargyl 
alcohol as the three carbon synthon. C-Alkylation with bromobutane 
furnishing the alkynol 9, was accomplished by treatment of propargyl alcohol 
with lithium amide in liquid ammonia followed by the addition of the alkyl 
halide (scheme 3.3). 
The triple bond in alkynol 9 was made to migrate to the terminal position by 
employing the Brown acetylene zipper.6 Thus, treatment of 9 with the 
potassium salt of 1,3-diaminopropane (КАРА) provided alkynol 10, which was 
subsequently protected as a the tetrahydropyranyl ether 11 upon reaction 
with dihydropyran in the presence of pyridinium />toluenesulfonate (PPTS) as 
the catalyst. This protected acetylene 11 was then used in the ring-opening 
reaction of 5-(-)-methyloxirane to give the partially protected alkynediol 12 
(scheme 3.3). 
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10 
Т Н Р - 0 ^ \ / \ ^ — = - н »• ТНРО
> 
о. 
11 • , 12 он 
a. LÌNH2, NHafliq), 95%; b. Potassium 3-aminopropyl amide (КАРА), 59%; 
с. Dihydropyran. PPTS, CH2CI2, 98%; d. BuLi, HMPA, 8. THF, 56%. 
Scheme 3.3 
The primary hydroxyl group of this alkyndiol must be converted into a 
phosphonium salt for its use in the projected chain elongation (see scheme 
3.1). For this purpose, the secondary alcohol group in 12 first was protected 
with a /e/7-butyldimethylsilyl group. This group was selected as it will withstand 
the conditions necessary to remove the tetrahydropyranyl ether and also 
those of the further operations needed to prepare the phosphonium salt, viz. 
tosylation, bromide formation and coupling with triphenylphosphine. The 
resultant product 13 was then treated with magnesium bromide to remove 
selectively the THP-ether group to give the primary alcohol 14. The use of 
magnesium bromide is preferred over the usual acid conditions for this 
deprotection reaction because the silyl group may not be fully inert to acid 
treatment. In the following sequence of operations this primary alcohol was 
converted into the phosphonium salt 17. Thus, treatment of 14 with p-
toluenesulfonyl chloride in the presence of an excess of tetrabutylammonium 
bromide gave, via the intermediate tosylate 15, the terminal bromide 16 in 
86% yield based on the alcohol 14. The resultant bromide 16 was coupled 
with triphenylphosphine in the normal manner (scheme 3.4). 
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THPO4 
12 
- ч Х І Н 
= ч^ ^OTBDMS 
13 Ύ 
14 
= s^ ^OTBDMS 
Ύ 15 
= ^ .OTBDMS 
Ύ 
= ^ .OTBDMS 
Ύ 
α. TBDMSiCI, imidazole, DMF, 91%; b. MgBr2. Et20, 63%; с TosCI, л>Ви4ІЧВг, pyridine, 
CH2CI2, 86%; d. РИзР, acetonitrile, 22%, (recovered 16, 67%). 
Scheme 3.4 
When the a b o v e coupl ing reaction is carried out in toluene, the phosphonium 
salt precipitates a n d helps the reaction to p r o c e e d to c o m p l e t i o n , but further 
experiments demonstrated that higher yields c a n b e a c h i e v e d using 
acetonitrile, in which the phosphonium salt remains in solution. 
The synthesis of the phosphonium salt 17 presented a b o v e is analogous to 
that used by Zwanenburg et al.7 in their total synthesis of (-)-aspicilin. The 
difference is that they used a benzyl ether for the protect ion of the secondary 
alcohol. As a c o n s e q u e n c e thereof the removal of the THP ether c o u l d b e 
performed by convent ional ac id t reatment (/>toluenesulfonic a c i d in 
methanol). 
The required 5-(-)-2-methyloxirane was o b t a i n e d from ethyl L-(-)-lactate by 
using well-described procedures. 2 It is noteworthy, however, that in o n e report 
2.5 equivalents of lithium aluminum hydride w e r e e m p l o y e d under reflux 
conditions for 24 hours to reduce the ester function, whilst in another 
procedure the use of a limited a m o u n t of the same reducing a g e n t for 2 
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hours at room temperature was recommended. The yields in both cases were 
the same. 
Quinkert et al? also used 5-(-)-2-methyloxlrane as the Chiron to introduce the 
required stereochemistry at C(17) of the target molecule. The oxirane was 
ring-opened with a THP-protected Grignard reagent derived from 8-
bromooctan-1-ol in the presence of cycloocta-l,5-diene-copper(l) chloride, 
as the complexing agent. 
3.4 Synthesis of a precursor of aspicilin 
It was contemplated to use the phosphonium bromide 17, after standard 
deprotonation, in a Wittig condensation with the aldehyde function of the 
carbohydrate synthon 18. Since this aldehyde can be stored for considerable 
periods of time without any decomposition or formation of impurities, it implied 
that a low reactivity of the aldehyde function could be expected. 
= ^ JDTBDMS 
Br P h 3 P . ^ / \ ^ \ ^ = s^OTBDMS 
17 ' A4 '0N ) . . , iOBn 
Y 
18 
a. BuLi, 18, THF, 38%. 
Scheme 3.5 
A yield of less than 20 % had been recorded previously by Quinkert et al.B for 
a similar Wittig reaction with the synthon 18. This re-iterated the low reactivity 
of the aldehyde group. When the Wittig reaction of 18 with the ylid of 
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phosphonium salt 17 was performed, however, it was found that yields of 19 
of over 50% could be achieved (scheme 3.5). 
It may have been expected that the product 19 of the above condensation 
could adopt an E- or /-geometry about the created double bond. The Z-
alkene was expected to be more favoured since the reaction involves a non-
stabilized ylid.9 It was difficult to discriminate between the two products using 
either iH-NMR spectral data or TLC characteristics. This double bond will be 
hydrogenated at a later stage {vide infra] and no further efforts were 
expended in attempting to determine the ΕΙ Ζ ratio since both stereoisomers 
are acceptable. 
The next step in the sequence ¡s the introduction of a phosphonium salt 
containing unit at the C(l7) secondary alcohol function. For this purpose the 
silyl protecting function was selectively removed by treatment of the product 
19 with tetrabutylammonium fluoride in tetrahydrofuran. 
о 
Y u Y ^ p p h 3 a 
a. Tetrabutylammonium fluoride (TBAF), THF, 84%; b. Chloroacetic anhydride, 
NaHCOs, DMF, 90%; с Ph3P, acetonitrile, 84%. 
Scheme 3.6 
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Subsequent react ion of the free alcohol with either chloroacetyl chloride or 
chloroacet ic anhydride in pyridine gave the ester 21 (scheme 3 6) This ester 
group forms the basis of the lac tone function in the natural product 1 
Treatment of 21 with tnphenylphosphine in either to luene or acetonitnle gave 
the phosphonium salt 22 The phosphonium salt that precipi tated from 
toluene was prone to decomposi t ion, whereas the product solubihzed in 
acetonitnle was stable and ob ta ined in 84% yield (scheme 3 6) 
This phosphonium salt 22 already contains the comp le te carbon framework of 
the ult imate product It was p lanned to reduce the doub le and triple bonds 
concurrently with the removal of the glycosidic benzyl group 
Catalyt ic hydrogénat ion of the phosphonium salt 22 with palladized charcoal 
indeed caused the reduct ion of both unsaturated bonds, but the ^ -NMR 
spectrum of the product revealed that the benzyl group was still present and 
hence that the product was not the desired hemi-aceta l 24 (scheme 3 7) 
Y°Y^pph3ci 
' ° ' .rtOBn 
X 22 
Cl 
s + 
О г О 
Χ 24 25 Ο Η 1 0 Η 
a H2 Pd(C) EtOH 85% 
Scheme 3 7 
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By varying the conditions1013 of this process, i.e. the use of increased 
temperatures and pressures, addition of extra amounts of catalyst, and 
employment of other solvents, failed to cause hydrogenolysis of the benzyl 
group. 
Although it had been demonstrated earlier (see scheme 3.2) that 
phosphonium salts are stable to the conditions of hydrogenolysis it was 
considered necessary to confirm that the above material had not undergone 
any reactions other than the expected reductions. Treatment of the material 
with methanolic K2CO3 followed by benzaldehyde gave material 26 whose 
iH-NMR spectral characteristics were consistent with those expected for a 
cinnamic ester (scheme 3.8). 
The disappointing conclusion is that the inability to remove the benzyl 
protecting group precludes completion of the synthesis of the target 
molecule. The envisaged final steps are included in scheme 3.7. 
1 a 
Xo -
a. Benzaldehyde, КгСОэ, MeOH 
Scheme 3.8 
'X° » 
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3.5 Discussion 
All the steps required for the preparation of the precursor 23 for the aspicilin 
synthesis could be realized without serious problems. Unfortunately, the crucial 
liberation of the latent aldehyde function by hydrogenolytic removal of the 
benzyl group in 23 failed and is, therefore, a major obstacle in this Wittig 
approach to the total synthesis of aspicilin 1. 
Difficulties with the debenzylation of analogous structures were also 
encountered previously during the synthesis described in Chapter 2 (section 
2.4). In that case the problem could be solved by employing a different 
deprotection method, viz. reduction with sodium dissolved in liquid ammonia. 
This method cannot be applied for 23, as it is not compatible with the 
phosphonium salt. 
It seems that the debenzylation of a benzyl glycoside of this type depends on 
subtle structural factors (see discussion in section 2.5). 
Quinkert et a/.8 reported the successful hydrogenolytic debenzylation of a 
similar precursor of aspicilin, having an acetate or a /er/-butyldimethylsilyloxy 
at the C(l7) position. When the C(l7) hydroxyl is protected with an 
ethoxyethyl group (section 2.4) hydrogenolysis of the benzyl group could, 
however, not be accomplished. 
The choice of the Chiron for the introduction of the correct chirality at C(l7) 
deserves some comments. In Chapter 2 the actual Chiron was ethyl 3-
hydroxybutanoate which was obtained from ethyl acetoacetate by a bio-
reduction using Bakers' yeast.2 This reaction is somewhat capricious with 
respect to the enantiomeric purity of the reduction product, and, therefore, 2-
methyloxirane is preferred as chiron, in spite of the fact that its volatility (bp 34 
°C) makes the handling slightly difficult, especially on a small scale. 
The overall conclusion of the work described in this chapter is, that, although 
ring closure via the Wittig olefination procedure was not successful in this 
stage, this elegant approach merits further investigation. 
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3 6 Experimental 
General methods Ή NMR spectra were recorded on Vanan EM 390 (90 MHz, 
CW) Bruker AC-100 (100 MHz FT) Bruker WM-200 (200 MHz FT) or Bruker AM-
400 (400 MHz FT) spectrometers with МедБі or CDCI3 as internal standards 1 3C 
NMR spectra were recorded on a Bruker AC 100 (100 MHz FT) or a Bruker AM 
400 (400 MHz FT) spectrometer with CDCI3 as the internal standard IR spectra 
were recorded using a Perkm-Elmer 298 spectrophotometer For mass 
spectroscopy a double focusing VG 7070E spectrometer was used Melting 
points were determined on a Reichert Thermopan microscope and are 
uncorrected Thin-layer chromatography (TLC) was performed using silica gel 
plates (F-254 Merck) Compounds were visualized with a UV lamp, 3% H2SO4 
in EtOH/140 °C or 0 1 M K2Cr207 / 1 M H2SO4 (20 1) Flash-column 
chromatography was performed using silica gel 60H (Merck) at a pressure of 
1 5 bar in the solvent mixtures indicated GLC was conducted with a Hewlett 
Packard HP 5790A or HP 5890 gas Chromatograph using a capillary HP cross-
linked silicone column (25 m χ 031 mm) connected to a HP 3390 or HP 5890 
calculating integrator 
Dichloromethane and acetonitnle were distilled from P2O5 petroleum ether 
and hexane were distilled from CaH2 diethyl ether was pre-dned over CaCI2 
and distilled from NaH toluene was distilled from Na, THF was distilled from 
L1AIH4 and pyridine and tnethylamme were distilled from KOH 
Experimental details for preparing lactol 5 is described in Chapter 2 (see 
compound 12) 
Propyloxycarbonylmethylenetnphenylphosphophorane 4 A solution of 
tnphenylphosphme (2 88 g 11 0 mmol) and allyl chloroacetate (l 35 g, 10 0 
mmol) in toluene (15 ml) was heated under reflux and the reaction was 
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monitored by TLC. Upon completion, the suspension was cooled to room 
temperature and the precipitated salt was isolated by filtration, washed with 
petroleum ether and dried (MgSCu) to give a yellow sticky substance 2. This 
material was dissolved in ethyl acetate (30 ml), treated with palladized 
charcoal (5%, 100 mg), and hydrogenated (1 atm) until no further H2 was 
consumed. The insoluble material was removed by filtration through a layer 
(co3 mm) of "hyflo", the inorganic material washed with ethyl acetate (10 ml) 
and the combined filtrate and washings concentrated in vacuo to give 
phosphonium salt 3. This phosphonium salt was dissolved in water (300 ml), 
treated with Phenolphthalein (2 drops) and titrated with aqueous sodium 
hydroxide solution (IN NaOH) until the color of the solution changed from 
colorless to pink. The aqueous solution was decanted from the precipitated 
phosphorane. The residue was washed with water (100 ml) and dried to give 
ylid 4 as a yellow sticky substance (2.93 g, 81 %). 
{2E,4R,5S,¿RJ 4,5-0-lsopropylidene-4,5,6-trihydroxy-non-2-enedioic acid 1-
propyl ester 9-ethyl ester 6 and {2l,4R,£>,<SRJ 4,5-0-isopropylidene-4,5,6-
trihydroxy-non-2-enedioic acid 1-propyl ester 9-ethyl esteri. A stirred mixture 
of compound 5 (360 mg, 1.38 mmol) and ylid 4 (880 mg, 2.43 mmol) in dry 
dichloromethane (25 ml) was set aside at room temperature until analysis 
(TLC, hexane/EtOAc 4:1) indicated completion of reaction [ca 6h), 
concentrated in vacuo ano column chromatography (hexane/EtOAc 5:1) of 
the crude material gave the Z-ester 7 (84 mg, 18 %).'H-NMR (100 MHz, CDCI3): 
δ 6.44 (dd, IH, J (H-C(3), H-C(2)J = 11.5. J (H-C(3), H-C(4)) = 6.7, H-C{3)); 5.86 
(dd, 1 H, J (H-C(2), H-C(3)) = 11.5. J (H-C(2), H-C(4)) = 1.8, H-C(2)); 5.53 (ddd, 1 H, 
J (H-C(4), H-C(2)) = 1.8. J (H-C(4), H-C(3)) = J (H-C(4), H-C(5))= 7.2, H-C(4)); 4.33 
(dd, IH, J (H-C(5). H-C(4)) = 7.3, J (H-C(5), H-C(6)) = 2.3, H-C(5)); 4.14-3.94 (m, 
4H, H2C(1') + H2C(1")); 3.51-3.28 (m, IH, after treatment with D 2 0: dt, J (H-C(6), 
H-C(5)) = 2.2, J (H-C(6), H-C(7)) = 7.8, H-C(6)); 2.37 (t, 2H, J (H-C(8), H-C(7)) = 7.7, 
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H2C(8)); 1.94 (d, IH, J (HO, H-C(6)) = 9.7, OH); 1.85-1.43 (m, 4H, H2C(7) + 
H2C(2')); 1.46 (s, 3H, H3C(i-prop.)); 1.33 (s, 3H, H3C(i-prop.)); 1.17 (t, 3H, J (H-
C(2"), H-C(l")) = 7.1. H3C(2")); 0.89 (t, 3H, J (Н-С(З'), H-C(2')) = 7.3, H3C(3')). MS 
(CI): m/e (%) 345 (7, M + +l), 329 (9, -CH3), 299 (20, -EtOH), 283 (32), 269 (16), 239 
(65), 227 (20), 213 (28), 199 (43), 181 (100), 157 (28), 155 (42), 131 (27), 126 (42), 
113 (67), 97 (44), 85 (95), 68 (10), 59 (28), 43 (93), 41 (49). 
Further elution gave the 5-ester 6 (201 mg, 42 %): iH-NMR (100 MHz, CDCI3): δ 
6.98 (dd, IH, J (H-C(3), H-C(2J) = 15.6, J (H-C(3), H-C(4)) = 6.4, H-C(3)); 6.09 (dd, 
1H, J (H-C(2), H-C(3)) = 15.6, J (H-C(2), H-C(4)) = 1.3, H-C(2)); 4.74 (ddd, 1 H, J (H-
C(4), H-C(2)) = 1.3, J (H-C(4), H-C(3)) = J (H-C(4). H-C(5))= 6.6, H-C(4)); 4.23-4.02 
(m, 5H, H-C(5) + H2C(1') + H2C(1")); 3.59 (quint., IH, J (H-C(6), H-C(5)) = J (H-
C(6), H-C(7)) = J (H-C(6), HO) = 5.8, after treatment with D 2 0: q, H-C(6)); 2.49 
(t, 2H, J (H-C(8), H-C(7)) = 7.7, H2C(8)); 2.26 (d, IH, J (HO, H-C(6)) = 5.8, OH); 
1.87-1.59 (m, 4H, H2C(7) + H2C(2')); 1.55 (s, 3H, H3C(i-prop.)); 1.44 (s, 3H, H3C(i-
prop.)); 1.25 (t, 3H, J (H-C(2"), H-C(l")) = 7.1, H3C(2")); 0.96 (t, 3H, J (Н-С(З'), H-
C(2')) = 7.3, НзС(З')). MS (CI): m/e (%) 345 (13, M + +l), 329 (13, -CH3), 299 (45, -
EtOH), 283 (47), 269 (9), 239 (76), 227 (15), 213 (29), 199 (24), 181 (63), 157 (39), 
155 (8), 131 (40), 126 (46), 113 (23), 97 (42), 85 (85), 68 (10), 59 (26), 43 (100), 41 
(41). 
Oct-2-уп-І-оІЪ. Liquid ammonia (ca250 ml) maintained at -80°C and under 
N2 was treated with a small piece of clean lithium metal [ca 100 mg) 
whereon the mixture turned blue. Lithium metal [4.02 g, 579 mmol) was then 
added carefully to the stirred mixture which turned into a gray suspension 
after ca 20 min. The stirred suspension was treated with a solution of prop-2-
yn-l-ol (16.7 g, 298 mmol) in dry THF (25 ml) over 15 min, set aside for 1.5 h and 
then treated dropwise over 1 h with 1-bromopentane (15.1 g, 100 mmol) in 
dry THF (25 ml). Analysis (GLC) after a further 1.5 h indicated no unreacted 1-
bromopentane. The ammonia was allowed to evaporate at room 
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temperature and the residue was treated with a mixture of ether (200 ml) and 
water (200 ml), the aqueous layer extracted with ether (3 χ 50 ml) and the 
combined ether layers washed with water (200 ml), dried (MgSCM) and 
concentrated in vacuo to yield 9 (12 0 gr, 95 2 mmol, 95 %) as a colourless oil 
iH-NMR (90 MHz, CDCI3) 5 4 21 (bs, 2H H2C(1)), 2.67 (bs, 1 H, OH); 2 29-2 13 (m, 
2H, H2C(4)); 1 58-1 24 (m, 6H, H2C(5)+H2C(6)+H2C(7)); 0.95 (t, 3H, J (H-C(8), H-
C(7)) = 5.4, H3C(8); IR (film, cm ') ν 3600-3100 (OH), 2950/2930/2860, 2280/2220 
(C=C, alkyne), 1455, 1135, 1010 
Oct-7-yn-l-ol 10 Liquid ammonia (100 ml) maintained at -80°C and under 
nitrogen was treated while stirring with potassium metal (7 82 g, 200 mmol), 
added in small pieces After ca 30 mm the original clear dark blue solution 
became a gray suspension whereon it was treated with l ,3-diammopropane 
(120 ml) to give a black suspension, which was stirred for 30 mm and then 
warmed to ca 50°C in vacuo to evaporate residual ammonia The black 
suspension was heated (80°C) and treated with a solution of compound 9 
(8 50 g, 67 5 mmol) in dry THF (25 ml), set aside until analysis (GLC) indicated 
completeness of reaction [cal h), and poured onto ice (200 g) The mixture 
was extracted with ether (3 χ 30 ml) and the combined ether layers washed 
with water (100 ml), dried (MgS04), concentrated in vacuo and distillation 
(58°C/0.4 mm Hg) of the residue gave compound 10 (5 05 g, 40 l mmol, 59%) 
as a colourless oil. 'H-NMR (90 MHz, CDCI3) 5 3.54 (m 2H, H2C(l)), 2 34-2 04 (m, 
3H, H2C(6)+OH), l 90 (t, IH, J (H-C(8), H-C(6)) = 2 0, H-C(8)), Ι 65-1 28 (m, 8H, 
H2C(2) + H2C(3) + H2C(4) + H2C(5)), IR (film, cm ') • ν 3600-3200 (OH) 
2920/2860, 2120 (C-C, alkyne) 
1}-0-(2'-Tetrahydropyranyl)-oct-7-yn-ì'-0I'11 A stirred, cooled (0°C) solution of 
compound 10 (7 35 g, 58 3 mmol) in dry dichloromethane (100 ml) containing 
pyndmium p-toluenesulfonate (50 mg) was treated with a solution of 
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dihydropyran (5.40 g, 64.3 mmol) in dry dichloromethane (25 ml) and set aside 
overnight at room temperature. The mixture was treated with saturated 
aqueous sodium hydrogen-carbonate solution (50 ml) and the separated 
aqueous layer was extracted with dichloromethane (3 χ 30 ml). The 
combined organic extracts were washed with water (50 ml), dried (MgS04) 
and concentrated in vacuo to give compound 11 (12.0 g, 57.4 mmol, 98%) as 
a yellowish oil. iH-NMR (90 MHz, CDCI3): δ 4.60-4.48 (m IH, H-C(2')); 3.96-3.20 
(m, 4Н, H2C(l ) + Н2С(6')); 2.26-2.06 (m, 2Н. Н2С(6)); 1.90 (t, l H, J (H-C(8), Н-С(6)) 
= 2.1, Н-С(8)): Ì.77-1.25 (m, 14H, Н2С(2) + Н2С(3) + Н2С(4) + Н2С(5) + Н2С(3')+ 
Н2С(4') + Н2С(5')); IR (film, cm') : ν 3280, 2920/2860, 2120 (C=C, alkyne), 
1440/1450, 1350. 
ßj-lΊ'-(Tetrahydropyranyl-2'-oxy)-undec-4-yn-2-ol'12. BuLi (1.6 M in hexane; 24 
ml, 38.4 mmol) was added dropwise to a stirred, cooled (0°C) solution of 
compound 11 (7.64 g, 36.4 mmol) in dry THF (60 ml), which caused a change 
of colour from pale yellow to dark orange. The mixture was set aside for 20 
min, whereon it was cooled to -50°C and subsequently treated with HMPA (10 
ml) and dropwise with a solution of 5-(-)-2-methyloxirane 8 (2.40 g, 41.4 mmol) 
in dry THF (25 ml) and then set aside overnight. The mixture was treated with 
aqueous NH4CI solution (5M, 50 ml), the separated aqueous layer extracted 
with ether (3 χ 50 ml), the combined organic layers washed with water (100 
ml), dried ¡MgSCu) and concentrated in vacuo io give compound 12 (5.46 g, 
20.4 mmol, 56 %). 1H-NMR (90 MHz, CDCI3): δ 4.60-4.50 (m 1 H, H-C(2')); 3.94-3.20 
(m, 5Н, Н-С(2) + Н2С(11) + Н2С(6')); 3.04 (bs, IH, ОН); 2.31-2.01 (m, 4Н, Н2С(3) + 
Н2С(6)); 1.88-1.06 (m, 14Н, Н2С(7) + Н2С(8) + Н2С(9) + Н2С(Ю) + Н2С(3')+ 
Н2С(4') + Н2С(5')); 1.23 (d, ЗН, J (Н-С(1 ), Н-С(2)) = 6.3, Н3С(1 )); IR (film, cm ') : ν 
3600-3200 (OH), 2940/2860, 2240 (C=C, alkyne), 1455/1440, 1350, 1320, 1200. 
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ß)-2-fteu-Butyldimethylsilyloxy)-11-(tetrahydropyranyl-2'-oxy)-undec-4-yne 13 
A stirred solution of compound 12 (2 43 g, 9.07 mmol) in dry DMF (20 ml) was 
treated with imidazole (l 53 g, 22 5 mmol) and /etf-butyldimethylsilyl chloride 
(1.50 g , 10.0 mmol) and set aside at room temperature until analysis (TLC, 
hexane/EtOAc 2:1) indicated completeness of reaction {ca3 h) The mixture 
was treated with water (50 ml) and ether (50 ml), and the separated aqueous 
layer was extracted with ether (3 χ 20 ml) The combined organic layers were 
washed with water (50 ml), dried (MgSCu) and concentrated in vacuo to 
give compound 13 (3.16 g, 8 27 mmol, 91%) 'H-NMR (90 MHz, CDCI3)· δ 4.59-
452 (m IH, H-C(2')); 4.01-3 23 (m, 5Н, Н2С(1) + Н-С(Ю) + Н2С(6')), 2 34-2 03 (m, 
4Н, Н2С(6) + Н2С(9)); 1 82-1.34 (m, 14Н, Н2С(2) + Н2С(3) + Н2С(4) + Н2С(5) + 
Н2С(3')+Н2С(4') + Н2С(5')), 1.24 (d, ЗН, J (Н-С(11), Н-С(Ю)) = 6.0, Н3С(11)); 0.95 
(s, 9Н, С(СНз)зЬ 0 13 (s, ОН, Si(CH3)2); IR (film, cm >) · ν 2960/2860, 1475/1465, 
1380/1360/1355, 1255 
ß)-10-[\ert-butyldimethylsilyloxy)-undec-7-yn-1-ol 14 A stirred solution of 
compound 13 (3.32 g, 8.69 mmol) in dry ether (50 ml) was treated with a 
solution of MgBr2 [prepared by reacting Mg (846 mg) with 1,2-dibromoethane 
(6 54 g) in dry ether (25 ml)] and set aside overnight at room temperature. The 
mixture was treated with water (50 ml) and the separated water layer 
extracted with ether (2 χ 25 ml) The combined ether layers were dried 
(MgS04) and concentrated in vacuo to give 14 (l 64 g, 5 50 mmol, 63 %) Ή-
NMR (90 MHz, CDCI3)· δ 3.88 (sext., IH, J (H-C(IO), H-C(ll)) = 6.0, H-C(IO)); 3.56 
(t, 2H, J (H-C(l), H-C(2)) = 5.7. H2C(l)), 2.63 (bs, IH, OH); 2.30-2.02 (m, 4H, 
H2C(6) + H2C(9)), l 67-1.34 (m, 8H, H2C(2) + H2C(3) + H2C(4) + H2C(5)), l 22 (d, 
3H, J (H-C(ll), H-C(IO)) = 6.0, H3C(ll)); 088 (s, 9H, C(CH3)3), 0 10 (s, 6H, 
Si(CH3)2); IR (film, cm') . ν 3600-3200 (OH), 2980/2960/2870, 1470/1460, 
1380/1360, 1255. 
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ß)-ll-Bromo-2-(\eu-butyldimethylsilyloxy)-undec-4-yne 16 Treatment of 
compound 14 (943 mg, 3 Ì6 mmol) with />toluenesulfonyl chloride (I 02 g, 
5 35 mmol) and (/>Bu)4NBr (5 0 g, 15 5 mmol) in pyndme/dichloromethane 
and processing in the usual manner gave the bromide 16 (981 mg, 2 72 mmol, 
86%) 'H-NMR (90 MHz, CDCI3) δ 3 93 (sext, Ι Η, J (H-C(IO), H-C(l l)) = 6 l, H-
C(l0)). 3 55 (t 2H, J (H-C(l) H-C(2)) = 65 H2C(1)), 2 34-2.21 (m, 4H, H2C(6) + 
H2C(9)), l 87-1 35 (m, 8H, H2C(2) + H2C(3) + H2C(4) + H2C(5)), l 26 (d, 3H, J (H-
C(l l ) . H-C(IO)) = 6 1 H3C(11)J 0 94 (s, 9H C(CH3)3), 0 13 (s, 6H Si(CH3)2), IR 
(film cm 'J ν 2980/2930/2860, 1440/1430, 1370/1330, 1120. 
β J- ¡0-/\ert-Buty/d/mefhy/s//y/oxyJ-undec-7 yn- l-yltriphenylphosphomum 
bromide 17 A stirred mixture of the bromide 16 (350 mg, 970 μηηοΙ) and 
triphenylphosphine (300 mg, l 15 mmol) in dry acetonitnle (5 ml) was heated 
under reflux for 72 h and then concentrated in vacuo The residual foam was 
dissolved in a minimum amount of dry acetonitnle (2 drops) and washed with 
dry ether (10 ml) The ether was decanted and the residue was concentrated 
in vacuo This procedure was repeated, until no Ph3P/Ph3P=0 was observed 
in the ether washings Finally, concentration in vacuo gave compound 17 
(131 mg 210 μηιοΙ, 22%) iH-NMR (90 MHz, CDCI3) δ 804-7 66 (m, 15H, Ph3), 
4 09 3 59 (m, 3H, H2C(1) + H-C(IO)), 2 34-2 04 (m, 4Н, Н2С(6) + Н2С(9)), 1 90-1 31 
(m, 8Н Н2С(2) + Н2С(3) + Н2С(4) + Н2С(5)) 1 23 (d ЗН, J (H-C(ll), H-C(IO)) = 
6 2 H3C(11)), 0 93 (s, 9H С(СН3)3), 0 14 (s, ОН Si(CH3)2) Column 
chromatography of the concentrated ether washings yielded 236 mg (2 72 
mmol 67%) recovered 16 
Benzyl 2,3-0-isopropylidene-a-D-\yxo-pentodialdo-l,4-furanoside 18 The 
synthesis of compound 18 was described in chapter 2 (compound 10) 
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(4R, Π S, IΈ/IJ Benzyl 2,3-0-lsopropy/idene-4-[l I '-(\er\-butyldimethylsilyloxyj-
dodec-l'-en-8'-yn-!-y/J-a-i-er/\hro-furanoside 19 : BuLi (1.6 Μ ¡η hexane; 135 
μΙ, 216 μηιοΙ) was added dropwise to a stirred, cooled (0°C) solution of the 
phosphonium salt 17 (131 mg, 210 μΐηοΙ) in dry THF (IO ml), which caused a 
change of colour from pale yellow to dark orange. The mixture was set aside 
for 15 min, whereon it was treated dropwise with a solution of glycoside 18 
(60.0 mg, 216 mmol) in dry THF (5 ml) and set aside for 15 min (colour from 
orange to yellow). The mixture was treated with saturated aqueous NH4CI 
solution (10 ml), extracted with ether ( 3 x 5 ml), the combined organic layers 
washed with water (10 ml), dried (MgSCU) and concentrated in vacuo to give 
compound 19 (43.5 mg, 80.3 μηηοΙ, 38 %). iH-NMR (90 MHz, CDCI3): δ 7.28 (s, 
5H, arom.); 5.89-5.53 (m, 2H, H-C(l')+H-C(2'); 5.10 (s, IH, H-C(l)); 4.84-4.42 (m, 
5H, H-C(2)+H-C(3)+H-C(4)+H2C-Ph); 3.91 (sext., IH, J (H-C(ll'), H-C(l2')) = 6.0, 
H-C(IV)); 2.33-2.00 (m, 6H, H2C(3')+ H2C(7') + H2C(lO')); l.58-1.20 (m, 12H, 
H2C(4') + H2C(5') + H2C(6') + 2 H3C(i-prop.)); 1.24 (d, 3H, J (H-C(12'), H-C(ll')) = 
6.0, H3C(12')); 0.93 (s, 9H, C(CH3)3); 0.12 (s, 6H, Si(CH3)2). 
(4R, / / S, / E/Zy Benzyl 2,3-0-isopropylidene-4-(11 '-hydroxy-dodec-1 '-en-8'-yn-l-
y/J-a-L-eryihro-furanoslde 20 : Tetrabutylammonium fluoride (1.0 M in THF; 160 
μΙ) was added dropwise to a stirred solution of compound 19 (43.5 mg, 80.3 
μηηοΙ) in dry THF (2 ml). The mixture was set aside for 2 h, treated with saturated 
aqueous NH4CI solution (5 ml) and the separated water layer extracted with 
ether (2x5 ml). The combined organic layers were washed with water (5 ml), 
dried (MgSCU) and concentrated In vacuo to give compound 20 (28.7 mg, 
67.1 μη-ιοΙ, 84 %). ÌH-NMR (90 MHz, CDCI3): δ 7.34 (s, 5H, arom.); 5.93-5.55 (m, 
2H, Н-С(Г)+Н-С(2'); 5.14 (s, IH, H-C(l)): 4.88-4.47 (m, 5H, H-C(2)+H-C(3)+H-
C(4)+H2C-Ph); 3.90 (sext., IH, J (H-C(l Γ), H-C(l2')) = 6.1, H-C(l 1')); 2.38-1.96 (m, 
7H, H2C(3')+ H2C(7') + H2C(10') + OH); 1.67-1.13 (m, 12H, H2C(4') + H2C(5') + 
H2C(6') + 2 H3C(i-prop.)); 1.23 (d, 3H, J (H-C(12r), H-C(l Γ)) = 6.2, H3C(12')). 
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/7S,4'R /CE/zy //' (1"-Benzyl2"3"-0-isopropy/idene-a-i-eryihro-furanos-4" 
ylj-l'-methyl lO'-undecen-З-упуІ 2-chloroacetate 21 A stirred solution of 
chloroacetic anhydride (23 0 mg, 135 μηηοΙ) and ЫаНСОз (2 3 mg, 27 цтоі) 
in dry DMF (1 ml) was treated with a solution of compound 20 (28 7 mg, 67 1 
μηιοΙ) in dry DMF (1 ml), set aside for 1 5h treated with ice (5 g) and extracted 
with ether (5 ml) The ether layer was washed with water (5 ml) and dried 
(MgS04> Concentration in vacuo gave compound 21 (30 4 mg, 60 3 μηηοΙ, 90 
%) Ή-NMR (90 MHz, CDCI3) δ 7 32 (s, 5H arom ) 5 93-5 53 (m, 2H, H C(l')+H-
C(2')),5Ì2 (s, IH, Н-С(П). 505 (sext, IH J (H-C(ll'), H C(l2')) = 6 3, Н-С(ІГ)). 
4 86-4 44 (m, 5H H C(2")+H-C(3 )+H-C(4 )+H2C-Ph), 4 04 (s, 2H, H2C(2)), 2 54-
240 (m 2Н, H2C(lO)), 2 30-2 02 (m 4Н, Н2С(3)+ Н2С(7)), I 67-1 13 (m, 15H, 
Н2С(4') + Н2С(5') + Н2С(6') + Н3С(12')+ 2 Н3С(і prop )) 
/7 5 4'R ΙΟΈ/IJ [2-{11 ' (1 "-Benzyl-2' 3"-0-isopropylidene a-L-erythro furanos-
4' -ylj-1' methyl-10'-undecen-3' ynyl}oxy]-2 oxoethyltriphenylphosphomum 
chloride 22 . A stirred mixture of compound 21 (30 4 mg, 60 3 μίτιοΙ) and 
tnphenylphosphine (20 mg, 76 3 μπιοΙ) in dry acetonitnle (5 ml) was heated 
under reflux until analysis (TLC, hexane/EtOAc 24) indicated complete 
consumptiom of 21 (approx 60h) The mixture was concentrated in vacuo, 
the residue dissolved in the minimum amount of dry acetonitnle and washed 
with dry ether (10 ml) The ether was decanted and the residue was 
concentrated in vacuo This procedure was repeated until no Ph3P/Ph3P=0 
was observed in the ether washings Concentration of the residue in vacuo 
gave compound 22 (39 0 mg, 50 9 μΓηοΙ, 84%) Ή-NMR (90 MHz, CDCI3) δ 
8 00-7 40 (m, 15Η, Ph3), 7 29 (s, 5H benzyl), 5 83-5 47 (m, 4H, H-C(l0)+H-C(l Ι) + 
Н2С-Р) 508 (s IH, H-C(l)) 487-442 (m, 6H H-C(l )+Н-С(2')+Н-С(3')+Н-
С(4')+Н2С Ph) 2 27-1 97 (m 6Н, Н2С(2) + Н2С(5) + Н2С(9)), 1 54-1 30 (m, 12H, 
Н2С(6) + Н2С(7) + Н2С(8) + 2 Н3С(і-ргор )), 1 13 (d, ЗН, J (Н3С-С(1), Н-С(1)) = 
60 Н3СС(1)) 
87 
Chapter 3 
(1 Ъ,4'Ъ) [2-{l 1 '-fi "-0-ßenzy/-2",3"-0-isopropy/idene-a-L-ery]hro-furanos-4"-
yl)-l'-methylundecyl}oxy]-2-oxoethyltriphenylphosphonium chloride 23 : A 
solution of compound 22 (39.0 mg, 50.9 μηηοΙ) in ethyl acetate (15 ml) was 
treated with palladized charcoal (5%, 50 mg), and hydrogenated (1 atm) until 
analysis (NMR, CDCIs) indicated complete reduction of the unsaturated 
bonds. The insoluble material was removed by filtration through a layer [ca3 
mm) of "hyflo", the inorganic material washed with ethyl acetate (10 ml) and 
the combined filtrate and washings concentrated in vacuo to yield 
compound 23 (24.1 mg, 31.3 μηηοΙ, 62%). 'H-NMR (100 MHz, CDCI3): δ 8.16-7.40 
(m, 15H, Ph3); 7.34 (s, 5H, benzyl); 5.75 (d, 2H, J (H-C-P, P) = 10.2, H2C-P); 5.11 (s, 
IH, H-C(l")); 4.92-4.09 (m, 6H, Н-С(Г)+Н-С(2")+Н-С(3")+Н-С(4")+Н2С-Рп); 1.60-
1.19 (m, 26H, Н2С(2'-1Г) + 2 Н3С(і-ргор.)); 1.04 (d, ЗН, J (Н3С-С(Г), H-C(l')) = 
6.0, НзС-С(Г)). 
(1 'S,4"Rj [2-{11 '-(1 "-0-ßenzy/-2",3"-0-isopropy/idene-a-L-e\yihro-furanos-4"-
ylj-l'-methylundecyl(E)-3-phenyl-2-propenoate : A solution of benzaldehyde 
(5.6 mg, 53.1μΓΓΐοΙ) in dry methanol (5 ml) was added dropwise to a stirred 
solution of the phosphonium salt 23 (24.1 mg, 31.3 μηηοΙ) and K2CO3 (2.5 mg, 
17.7 μηηοΙ) in dry methanol (10 ml). The mixture was set aside for 2 h, whereon 
it was treated with saturated aqueous NH4CI solution (10 ml), extracted with 
ether (3x5 ml), the combined organic layers washed with water (10 ml), dried 
(MgSCU) and concentrated in vacuolo give 26 (14.2 mg, 25.6 μίτιοΙ, 84%). Ή -
NMR (100 MHz, CDCI3): δ 7.85-7.30 (m, 11 Η, Н-С(З), C(3)-Ph, benzyl); 6.44 (d, 1 H, 
H-C(3)); 5.15-4.95 (m, 2H, H-C(l') + H-C(l")); 4.80-4.42 (m, 4H, H-C(2")+H-C(3")+ 
H2C-Ph); 3.97 (t, IH, J (H-C(4"), H-C(ll')) = 6.9, H-C(4")); 2.10-1.21 (m, 29H, 
H2C(2'-1 Г) + 2 H3C(i-prop.) + H3C-C(1)). 
88 
A ttempted synthesis of f+J-aspici/in... 
3.7 References 
1. Le Floe'h. Y.; Yvernaux. F.; Toupet, L; Grée. R. Bull. Soc. Chlm. Fr., 1991, 128, 742; Yvernaux, 
F.; Le Floc'h, Y.; Grée, R. Tetrahedron Leti.. 1989, 52. 7397; Yvernaux, F.; Le Floc'h, Y.; Grée, 
R.; Toupet, L. Tetrahedron Lett. 1989, 52, 7393. 
2. Seuring, В.: Seebach, D. Helv. Chlm. Acta, 1977, 60, 1175. 
3. Isler, О.; Gutmann, H.; Montavon, M.; Rüegg. R.; Ryser, G.; Zeller, P. Helv. Chlm. Acta. 
1957, 40. 1247. 
4. Nicotra, F.: Russo, G. Tetrahedron Lett. 1984, 25, 5697; Fraser-Reid, В.; Dawe, R.D.; Yulshian. 
D.B. Can. J. Chem.. 1979, 57, 1746; Nicotra, F.; Rochetti, F.; Russo, G. J. Org. Chem. 1982, 
47, 5381; Drew, M.G.B.; Kane, P.D.; Naili, M. J. Chem. Soc, Perkln Trans. I, 1988, 433. 
5. Orui, H.; Jones, G.H.; Moffatt, J.G.; Maddox, M l . ; Christensen, A.T.; Byram, S.K. J. Am. 
Chem. Soc. 1975, 97, 4602. 
6. Brown, Ch.A. J. Org. Chem. 1974, 39 3913. 
7. Woanders, P.P.; Thijs, L; Zwanenburg, В. Tetrahedron Lett. 1987, 28. 2409. 
8. Quinkert, G.; Fernholz, E.; Eckes, P.; Neumann, D.; Dürner, G. Helv. Chlm. Acta 1989, 72. 
1753. 
9. Johnson, A.W. Y/id Chemistry, Academic Press, New York and London, 1966. 
10. Kieboom, A.P.G.; Rantwijk, F. van Hydrogénation and hydrogeno/ysis in synthetic organic 
chemistry. Delft University Press, 1977. 
11. Bieg, T.; Szeja, W. Carbohydr. Res., 1990, 205. C10-C11. 
12. Landini, D.; Montanari, F.; Rolla, F. Synth. Commun.. 1978, 771. 
13. Hanessian, S.; Liak, T.J.; Vanasse, B. Synth. Commun., 1981, 396. 
89 
Chapter 3 
90 
Studies towards the synthesis... 
CHAPTER 
STUDIES TOWARDS THE SYNTHESIS OF AN 
ELEVEN-MEMBERED RING MACROLIDE 
4.1 Introduction 
A spicilin is an eighteen-membered ring macrocyclic lactone containing a trans α,β-unsaturated ester unit. In this relatively large-ring macrolide the inherent conformational and ring strain will be 
close to negligible. The question arises whether smaller-ring analogues of this 
macrocycle can be prepared and, if so, how the strain would manifest itself. 
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For this purpose the synthesis of an eleven-membered ring analogue of 
aspicilin, viz. compound 1, was undertaken. It is well documented that 
lactones of this ring size suffer from a considerable ring strain. 
Retrosynthetically, this target molecule 1 can be approached from the 
synthetic building blocks that have been utilized in the preceding chapters, 
namely the key intermediate aldehyde 2 (see also compound A in scheme 
2.1, and compound В in scheme 3.1), the protected 4-iodobutan-2-ol 3 and 
the allyloxycarbonylmethylenetriphenylphosphorane 4. It was planned to use 
fragment 3 in the chain elongation of fragment 2 by invoking a Wittig-type 
olefination reaction. 
For the ultimate ring closure a lactonization reaction was an obvious choice. 
The phosphorane 4 is a suitable reagent for introducing the unsaturated ester 
unit. 
Ч ^ ч ^ эн —-"N'-'^OPrg 0 0 3 4 
1 OH OPrg Д 
2 
Scheme 4.1 
4.2 Assembly of the three building blocks 
The first step towards the synthesis of the carbon framework of target 
molecule 1 is logically the coupling of the fragments 2 and 3 via a Wittig 
reaction. The ethoxyethyl protected iodide' 3 was converted into 
phosphonium salt 5 by simple treatment with triphenylphosphine. Under the 
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reaction conditions used, the ethoxyethyl protecting group was 
unexpectedly removed from the hydroxyl function. The free hydroxy group 
was, however, not expected to interfere with the synthetic operations to be 
performed. Subsequent deprotonation with A?-butyllithium gave the ylid which 
was reacted with the carbohydrate-derived aldehyde 2 to give an E/Z 
mixture of alkene 6 (scheme 4.2. The ratio of the E/Z isomers is not relevant 
because of the immediate reduction of the double bond by catalytic 
hydrogénation using palladized charcoal (5% Pd-C, H2, 45 psi). 
0 0 НО ^ ^ г ^ ! * ^ ' 0 "'ОВп 
- ì T T T 
^и 
°Ν...ιΟΒπ 0 0 
Λ 
°
ν
0 2 
Λ 
α. РРЬз, to luene, 70%; b. />BuLi, 2, THF, 55%. 
Scheme 4.2 
During this hydrogénation, removal of the benzyl ether from the glycosidic 
carbon atom took place concurrently to give hemi-acetal 7 (scheme 4.3). 
The third building block could now be introduced in a Wittig-like manner. 
Treatment of lactol 7 with ylid 4, obtained by deprotonation of the 
corresponding phosphonium salt as described2 in section 2.4 (scheme 2.11), 
gave, instead of the expected unsaturated ester 8, the cyclic product 9 
arising from an intramolecular Michael reaction3-7 of this intermediate. All 
attempts to trap the intermediate hydroxy alkene 8, failed. The cyclic Michael 
adduct 9, which is a C-glycoside, was obtained as a mixture of a and β 
anomers in the ratio of 7:3. 
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¿?~^Su^..aOBn 
ΥΛΤ' 
он Π 
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он Π 
γ 
О. , 0 
AIIO 
О 
он 
он ^ Ч ^ о ^ ^ 
-г° 
YWVV 
он У ν о Y 
^ ^ 
о . .0 
а. Нг, Pd-C, EtOAc, 70%; b. 4, CH2CI2, 82%. 
Scheme 4.3 
The same result was o b t a i n e d w h e n substrate 12, having the secondary 
a lcohol group p r o t e c t e d as an ethoxyethyl ether, was subjected t o the Wittig 
react ion with ylld 4 (scheme 4.4). Only the cyclic products 13 w e r e o b t a i n e d 
with a c o m p a r a b l e a/ß-ratio as was found for c o m p o u n d 9. 
0 ^ 0 ГЛ Y ο. ,ο 
12 
Χ AHO 
О 
A^PPh-
\ л х о ГЧ о 
*-> 
τ Y 
13 
a. 4, СН2СІ2 
Scheme 4.4 
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The C-glycoside 9 was converted into the corresponding free acid 10 by 
treatment with tetrakis-triphenylphosphine-Pd complex and morpholine.8 The 
hydroxy acid obtained thus was subjected to a Yamaguchi9 lactonization 
reaction using 2,6-dichlorobenzoyl chloride10 for the formation of the 
intermediate mixed anhydride followed by treatment with 4-
(dimethylamino)pyridine (DMAP)" to produce the tricyclic lactone 11 
(scheme 4.5). 
он ) \ о *" он ) \ о 
X X 
10 11 
a. (PPhsJiPd, morpholine, 84%; b. 2,6-Dichlorobenzoyl chloride, Et3N, THF, 
followed by DMAP, Δ, toluene, 31%. 
Scheme 4.5 
Although both epimers of 11 would have been expected, only one of them 
was isolated after column chromatography. An extensive ^-NMR 
spectroscopic analysis revealed that only the 1 tf-epimer (which is anti with 
respect to the adjacent alkoxy group) had been formed. The two protons on 
C(2), i.e. a to the carbonyl function, gave a signal at δ 2.5 ppm, as in the R-
epimer of the starting material 10, and the coupling constant of the C(2)-
proton of 11 with the adjacent proton on C(l4) was zero as with all the other 
benzyl a-D-mannofuranoside derivatives in this synthetic sequence to target 
molecule 1. 
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4.3 Discussion 
The results presented in the p r e c e d i n g section show that the intramolecular 
Michael react ion of the intermediate hydroxy a lkene ester 8 is apparent ly a 
very facile process Similar results w e r e described in Chapter 2 (scheme 2 12), 
with the essential d i f ference that in that case the γ-hydroxy alkene ester 
c o u l d b e t r a p p e d by a n a l c o h o l protect ing a g e n t Consequently the target 
molecule 1 c o u l d not b e p r e p a r e d by the chosen strategy. 
The very easy hydrogenolyt ic removal of the benzyl protect ing g r o u p from 
c o m p o u n d 6 was noteworthy This result is in sharp contrast with the difficulties 
encountered in the Chapters 2 a n d 3, schemes 2 11 a n d 3 7 respectively, 
where such a reduct ive d e p r o t e c t i o n could not b e accompl ished 
It is of interest t o c o m p a r e the 'H-NMR spectral characteristics of the tricyclic 
lactone 11 described here with l a c t o n e 14 o b t a i n e d in Chapter 2 (scheme 
2 18) 
Table 4 1 Ph vsical data of compounds 11 and 14 
9 
11 
11 
14 
ЬН С(5) 
4 85 
5 04 
8H-CI2) 
2 54 
2 49/2 30 
δΗ C( l ) 
4 28 
4 ál 
ЬН C( l4/2 l ) 
4 57 
4 48 
ftH C( l0/ l7) 
4 64 
4 59 
ί)Η C(9/I6) 
4 26 
3 82 
ЬН C(8/l5) 
I 87 
l 81 
h Н
Э
С C(5) 
1 25 
1 19 
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It is noteworthy that the Нг-С(2) exhibits ABX character in the less rigid 18-
membered ring system but not in the smaller, probably more strained 11-
membered ring system. 
4.4 Experimental 
General methods : ' H NMR spectra were recorded on Varian EM 390 (90 
MHz, CW), Bruker AC-100 (100 MHz, FT), Bruker WM-200 (200 MHz, FT) or Bruker 
AM-400 (400 MHz, FT) spectrometers with МедБі or CDCI3 as internal standards. 
13C NMR spectra were recorded on a Bruker AC-100 (100 MHz, FT) or a Bruker 
AM-400 (100 MHz, FT) spectrometer with CDCI3 as the internal standard. IR 
spectra were recorded using a Perkin-Elmer 298 spectrophotometer. Thin-
layer chromatography (TLC) was performed using silica gel plates (F-254, 
Merck). Compounds were visualized with a UV lamp, 3% H2SO4 in EtOH/140 
°C or 0.1 M К2СГ2О7 / 1 M H2SO4 (20:1). Flash column chromatography was 
performed using silica gel 60H (Merck) at a pressure of 1.5 bar in the solvent 
mixtures indicated. Dichloromethane and acetonitrile were distilled from 
P2O5, petroleum ether and hexane were distilled from CaH2, diethyl ether 
was pre-dried over СаСІ2 and distilled from NaH, toluene was distilled from 
Na, THF was distilled from ÜAIH4 and pyridine and triethylamine were distilled 
from KOH. 
f4S, IΈ/IJ Benzyl 2,3-0-isopropylidene-4-(4'-hydroxy-pent-1 '-eny/J-a-i-ery]hro-
furanosideG : BuLi (1.6 M in hexane; 0.41 ml) was added dropwise to a stirred, 
cooled (0°C) solution of the phosphonium iodide 5 (150 mg, 325 цтоі) in dry 
THF (5 ml). The mixture was set aside for 15 min, treated dropwise with a 
solution of aldehyde 2 (87.9 mg, 316 μηηοΙ) in dry THF (5 ml). After a further 15 
min the mixture was treated with saturated aqueous NH4CI solution (10 ml), 
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extracted with ether ( 2 x 1 0 ml), the combined organic layers washed with 
water (10 ml), dried (MgSCu) and concentrated in vacuo to give 6 (58.1 mg, 
174 μπηοΙ, 55 %) ìH-NMR (100 MHz CDCI3) δ 7 33 (s 5H, arom ), 5 89-5.72 (m, 
2H, H-C(l')+H-C(2'), 5 09 (s, IH, H-C(l)). 4 86-4 40 (m, 5H, H-C(2) + H-C(3) + H-
C(4) + H2C-Ph); 3 90 (sext, 1 H, J (H-C(4 ), H-C(3'J) = J (H-C(4'), H-C(5')J = 6 1, H-
C(4')),2 38-2 18 (m, 2H, H2C(3)), 1 85 (bs, IH, OH), 1 48 (s, 3H, H3C(i-prop ), 1 30 
(s, 3H, H3C(i-prop ), 1 23 (d, 3H, J (H-C(5"). H-C(4')) = 6 2, H3C(5')); IR (film, cm ') 
ν 3700-3150 (OH), 3030/3060/3085, 2975/2930, 2875, 1450, 1370 (C(CH3)2), 
1210, 1160, 1080 (C-O) 
(4%) 23-0-lsopropylidene-4-(4'-Hydroxy-pentyl)^-e\y\hro-furanose 7 . A 
solution of compound 6 (58 1 mg, 174 μπηοΙ) in ethyl acetate (20 ml) was 
treated with palladized charcoal (5% 50 mg) and hydrogenated (3 atm) at 
70°C until analysis (TLC, hexane/EtOAc 4 1) indicated completeness of 
reaction [circa 15 h) The insoluble material was removed by filtration through 
"hyflo' [ca 5mm) washed with ethyl acetate (20 ml) and the combined 
filtrate and washings concentrated in vacuo to give lactol 7 (30 0 mg, 122 
μηιοΙ, 70%) Ή-NMR (100 MHz, CDCI3) 5 5 33 (s, IH, H-C(l)), 4 71-4 54 (m, 2H, 
H-C(2)+H-C(3)),4 25(m, 4H, H-C(4) + H-C(4') + 2 OH), 1 81-1 11 (m 15H, Н2С(Г-
3) + H3C(4') + 2 НзС(і-ргор)), IR (film, cm') • ν 3600-3100 (OH), 
2970/2920/2870 1450, 1375 (C(CH3)2) 
Allyl f3aR,6R,6aS,4'Sj-[6'-f4"-hydroxy-penty/J-2:2'-d/methy/-tetrahydrofuro¡3 4-
d][l,3] dioxol-4'-yl]-acetate 9 A stirred solution of 7 (30 0 mg, 122 μηηοΙ) in dry 
dichloromethane (20 ml) was treated with phosphorane 4 (50.6 mg, 141 
μηηοΙ) heated under reflux until analysis (TLC, hexane/EtOAc 4 1) indicated 
completeness of reaction (co 2 5 h) and concentrated in vacuo Column 
chromatography (hexane/EtOAc 6:1 ) of the crude material gave compound 
9 (32 7 mg, 99 7 μηηοΙ, 82 %) ìH-NMR (100 MHz, CDCI3) δ 6 11-5 75 (m, 1 H, H-
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C(2-allyl)) 5 42-5 15 [m 2H H2C(3-allylJ), 4 73-3 45 (m. 8H. H-C(3a') + H-C(4') + 
H-C(6a ) + H C(6 ) + H-C(4 ) + H2C(l-allyl) + OH) 2 82 (d, 0 3 x 2H, J (H-C(2), H-
C(4')) = 6 5, H2C(2ß)J, 2 53 (d. 0 7 χ 2H, J (H-C(2). H-C(4')J = 7 7, H2C(2a)); 1.76-
1 16 (m 15H, H2C(l"-3 ) + H3C(4 ) + 2 H3C-C(2)) 
(3aR 6R,6aZ,4"ì>j-[6-(4n-Hydroxy-pentylì-2:2'-dimethyl-tetrahydrofuro[3,4-
d][l 3] dioxol 4'-yl]-acetic acid ΛΌ A stirred solution of ester 9 (6 5 mg, 19 8 
μίτιοΙ) in dry, oxygen free THF (5 ml) was treated with (PPr^Pd (2 3 mg, 2 0 
μίτηοΙ) and morpholine 17 ml (201 μίτιοΙ) and set aside at room temperature 
until analysis (TLC hexane/EtOAc 2 1 ) indicated completeness of reaction (ca 
2 h) The mixture was treated with saturated aqueous tartaric acid solution (5 
ml) and ether (10 ml) The separated aqueous layer was extracted with ether 
(2x5 ml) and the combined ether extracts were washed with water (10 ml), 
dried (MgSÜ4) and concentrated in vacuo to yield compound 10 (4.8 mg, 
16 7 μίτιοΙ, 84 %) ÏH-NMR (100 MHz CDCI3/D20) δ 4 96-4 80 (m, 03 x IH, H-
C(4ß)) 4 48(t 0 7 x l H , J (H-C(4a), H-C(2)) = 77 H-C(4'a)), 4 12-3.63 (m, 4H, Н-
C(3a ) + H-C(6a ) + Н-С(б') + Н-С(4")), 2 78 (d, 0 3 χ 2Н, J (Н-С(2). Н-С{4')) = 6.3, 
H2C(2ß)), 2 62 (d 0 7 χ 2Н, J (H-CÍ2). Н-С(4 )) = 7 7, H2C(2a)), 1 80-1 36 (m, 12H, 
H2C(1 3") + 2 Н3С-С(2 )) 1 23 (d ЗН J (Н-С(5 '), H-C(4"J) = 6 2, Н3С(4')) 
(№,£>.9R /ÖS 14RJ-5 12 12-Tnmethyl-4 11 13 15-tetraoxa-tricyclo[75 1.0ю"/-
pentadecan 3-one 11 A stirred solution of the hydroxyacid 10 (15.0 mg, 52.1 
mmol) in dry THF (2 ml) containing tnethylamme (5.8 mg, 57 4 μίτιοΙ) 
maintained under argon was treated with 2,6-dichlorobenzoylchlonde (ЮЗ 
mg, 52 2 μίτιοΙ) and set aside at room temperature for 2 h. At the end of this 
period the precipitated Et3N HCl was removed by filtration the filtrate diluted 
with dry toluene (25 ml) and added dropwise over 2 5 h to a boiling solution 
of DMAP (37 2 mg, 302 μίτιοΙ) in toluene (5 ml) The mixture was heated for a 
further l h set aside overnight at room temperature diluted with ether (20 
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ml), washed with saturated aqueous tartaric acid solution (10 ml), saturated 
aqueous sodium hydrogencarbonate solution (10 ml), water (10 ml) and the 
organic layer was dried (MgSCU) and concentrated in vacuo Column 
chromatography (hexane/EtOAc 5 1) of the residue gave compound 11 (4 4 
mg, 163 μηηοΙ, 31 %) Ή-NMR (400 MHz CDCI3) δ 4 88-4 82 (m, IH, H-C(5)), 
4 64(dd IH, J (H-C(IO) H-C(9))=32 J (H-C(10), H-C(14)) = 5 6, H-C(10)) 4 57 
(d, IH J (H C(14) H-C(10)) = 5 6 H-C(14)) 431-4 20 (m 2H H-C(l) + H-C(9)), 
2 54 (d, 2H J (H-C(2), H-C(l )) = 8 4 H2C(2)) 1 92-1 78 (m, 2H, H2C(8)), 1 66-1 50 
(m 4H H2C(6) + H2C(7), 1 47 (s 3H H3C-C(12)) 1 33 (s 3H H3C-C(12)) 1 25 (d, 
3H, H3C-C(5)) 
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Summary 
SUMMARY 
This thesis describes the stereoselective synthesis of the macrocyc l ic l a c t o n e 
aspicilin, onset t o a possible alternative synthetic route a n d the synthesis of a n 
e leven-membered a n a l o g u e of the macrol ide, all based on a 
monosaccharide as the starting material. 
In the first c h a p t e r a n overview is given of the various n o n - c a r b o h y d r a t e 
based syntheses that have been reported in the literature. 
In chapter 2 the total synthesis of (+)-aspicilin (schemes 1, 2, 3 a n d 4) is 
described, with the Yamaguchi react ion as the key step in the formation of 
the macrocycl ic l a c t o n e . Both D-mannose a n d D-arabinose c o u l d b e used as 
a starting materials for this synthesis. Due to the f a c t that D-arabinose g a v e 
low yields during its conversion to the actua l precursor, this route was not 
pursued further. 
The monosacchar ide D-mannose was c o n v e r t e d into Chiron 3 (scheme 1), 
which is the key intermediate for the work described in this c h a p t e r a n d the 
following t w o chapters. This Chiron is formally a d i a l d e h y d e a n d contains 
three stereogenic centers which correspond with the chirality at C(4), C(5) 
a n d C(6) in the target molecule 17. 
^ Д М
Д
 •=. "^ч *
1
 -. </-л-
Y У γ 
1 2 а 
a. DMP, acetone, SnCh, 76%; b. NaH, BnBr, DMF, 71%; с 80% aqueous acetic acid, 
96%; d. NalCU, acetone/water, 92%. 
Scheme 1 
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The fourth stereogenic center was derived by an enantioselective yeast 
mediated reduction of ethyl acetoacetate (scheme 2) and introduced via a 
coupling of building block 7 with alkynol 9 [obtained in two steps from 
propargyl alcohol] to give product 10 (scheme 3). 
a b Ε Ε ξ ° с E E § de E E ? 
ЛЛ^ ^ ^ А Л OEt ' — OEt 
a. Bakers yeast 98%; b EVE PPTS, CH2CI2 99%, с LiAIHU, Et 2 0. 99%; d TosCI pyridine, 
76%· e Nal Cu, a c e t o n e , 70% 
Scheme 2 
The hydroxyl group in compound 10 was converted through a series of 
reactions steps into the phosphonium salt 12. An important reaction in the 
sequence shown in scheme 3 is the acetylene zipper (reaction b) whereby 
the triple bond is migrated to the terminal position 
a b 
d e 
OEE 
10 
OEE 
a. L1NH2, С4Н9ВГ, ГчІНз(І) 95%, b KNH(CH2)3NH2, ЫНз(І) 66%, с. LiNH2, 7, NH3(I), 62%; d . 
TosCI pyridine CH2CI2 98% e Nal Cu a c e t o n e 85% f PPh3 acetonitnle 89%. 
Scheme 3 
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The salt 12 was used as the Wittig reagent in the first of the two coupling 
reactions with "dialdehyde" 3 When the benzyl group was removed from the 
anomenc center the second Wittig reaction could take place with 
allyloxycarbonylmethylenetnphenylphosphorane. In this way, the α,β-
unsaturated ester function of the target macrolide was introduced. 
The ring-closure reaction is an essential step in the sequence and for this 
purpose a modified Yamaguchi lactonization was used Subsequent removal 
of the protecting groups gave the target molecule aspicilin 17 in a 3% overall 
yield starting from D-mannose 
3 + 1 2 
14 OTBDPhS 
r ^ ^ O H 0 
/-^--*Ч/* ^ О k ^ ^ ^ ^ N ^ ^ v ^ O V - ^ \ ^ V ^ ^ s ^ * l 
S A I 
1 5 OTBDPhS 1 6 OTBDPhS 1 7 ÖH 
OH 
OH 
a 12 />BuLi 3 THF 50% b. H2 Pd-C EtOAc; с Na NH3(I), 73% (2 steps); d. 
Ph3P=CHC(0)OAII CH2CI2 e TBDPhSiCI imidazole, 78% (2 steps); f. MgBr2. Et20, 82%; 
g (PPhsbPd morpholine THF 69%· h 2,6-dichlorobenzoyl chloride, Et3N, THF 
followed by DMAP Δ toluene 53% ι TFA/НгО/МеОН (1:5*14), 68%. 
Scheme 4 
During this sequence, several difficulties were encountered. The 
hydrogenolysis of the glycosidic benzyl group was problematic, but this could 
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b e o v e r c o m e by removal of this protecting g r o u p with sodium in liquid 
a m m o n i a The second obstacle was the intramolecular Michael addit ion of 
the free hydroxyl g r o u p to the α,β-unsaturated ester t o form a mixture of a 
a n d β C-glycosides (scheme 5) The in situ protect ion of the free hydroxy 
group a v o i d e d this undesired react ion thus al lowing the complet ion of the 
synthetic sequence Additionally these Michael adducts c o u l d also b e 
transformed into ' Michael-macrolides ' 
OH V-OAII f ^ O E E О 
S W I O ^ N - C 
b d 
X 
14 OTBDPhS 
20 
a TBDPhSiCI imidazole b MgBr2 Et20 82% с (PPh3)<Pd morpholine THF 69% d 
2 6 dichlorobenzoyl chloride Et3N THF followed by DMAP Δ toluene 53% 
Scheme 5 
In the context of this successful total synthesis of aspicilm relevant literature 
reports w e r e also discussed 
In c h a p t e r 3 an alternative synthetic route is described wherein a Wittig t y p e 
react ion was p l a n n e d as the ultimate ring closure react ion using the hemi-
a c e t a l of the c a r b o h y d r a t e as a latent a l d e h y d e function 
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о 
Ai 
0
· ν .Λ>ΟΒη 
21 
Scheme 6 
Although the phosphonium salt could be synthesized, this attempt failed 
because the benzyl protecting group again could not be removed to 
provide the necessary free aldehyde function 
Chapter 4 describes some preliminary studies directed towards the synthesis 
of an eleven-membered ring analog, 23, of the natural product aspicilm. In 
the planned sequence the same building blocks 3, 7 and 24, as were used in 
chapter 2 for the synthesis of aspicilm could also be employed here 
4 ° ч .«OBn EEO 
OH OPrg A 
23 3 
Scheme 7 
Although it was quite convenient to use the same starting materials, the same 
difficulties mentioned in chapter 2 were again encountered, which resulted in 
an eleven-membered "Michael-macrolide" 
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SAMENVATTING 
Dit proefschrift beschrijft de stereoselective synthese van het 
macrocyclische lacton aspiciline, aanzetten tot een alternatieve synthese 
route van dit macrolide en de synthese van een 11-ring analoog van dit 
lacton, alles gebaseerd op een monosaccharide als uitgangsstof. 
In het eerste hoofdstuk wordt een overzicht gegeven van de diverse 
syntheseroutes beschreven in de literatuur, die niet gebaseerd zijn op 
koolhydraten. 
In hoofdstuk 2 is de totaalsynthese weergeven van (+)-aspiciline (schema 1, 2, 
3 en 4) met de Yamaguchi-reactie als belangrijke stap voor de vorming van 
het macrocyclische lacton. Zowel D-mannose als D-arabinose konden 
worden gebruikt als uitgangsstof voor deze synthese. Gezien het feit dat D-
arabinose lage opbrengsten gaf in the route naar de echte precursor 3, werd 
deze benadering niet verder uitgewerkt. 
Het monosaccharide D-mannose werd omgezet in Chiron 3 (schema 1), 
hetgeen het belangrijkste intermediair is voor het werk zoals beschreven in dit 
hoofdstuk en in de twee daarop volgende hoofdstukken. Dit Chiron is een 
verkapt dialdehyde met drie asymmetrische koolstofatomen die correspon­
deert met de chiraliteit van C(4), C(5) en C(6) van het doelmolekuul 17. 
O O 0 0 0 0 
λ λ X D-mannose .. , 
a. DMP, aceton, SnCb, 76%; b. NaH, BnBr, DMF, 71%; с 80% azijnzuur. 96%; d. NalCk 
aceton/water, 92%. 
Schema ! 
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Het vierde chirale centrum werd geïntroduceerd m.b.v. een 
enantioselectieve reductie van acetylazijnzure ethylester met bakkersgist 
(schema 2) hetgeen leidde tot intermediar 5. Dit product 5 werd omgezet in 
bouwsteen 7 dat vervolgens werd gekoppeld met alkynol 9 [gemaakt in 
twee stappen uitgaande van propargyl alkohol] resulterend in produkt 10 
(schema 3). 
0
 ° a.b E E§ ° с EE0- d.e E E ? 
4 5 
a. gist, 98%; b. EVE, PPTS, CH2CI2, 99%; с LiAlhk Et20, 99%; d. TosCI, pyridine, 76%; e. 
Nal, Cu, aceton, 70%. 
Schema 2 
De hydroxygroep van verbinding 10 werd omgezet, via een aantal stappen, 
in fosfoniumzout 12. Een belangrijke reactie in dit syntheseschema is de 
"acetyleenritser" waarbij de acetyleenband naar de terminale positie wordt 
gebracht (reactie b in schema 3). 
a b 
OEE 
10 
d,e 
OEE 
11 12 
OEE 
a. IJNH2, СдН9Вг, NH3(I), 95%; b. KNH(CH2)3NH2, NH3(I), 66%; с LiNH2, 7, NH3(I), 62%; d. 
TosCI, pyridine, CH2CI2, 98%; e. Nal, Cu, aceton, 85%; f. РРпз, acetonitril, 89%. 
Schema 3 
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Dit zout 12 was het Wittig-reagens in de eerste van de twee koppelings 
reacties van het 'dialdehyde' 3. Na verwijdering van de glycosidische 
benzylgroep kon de tweede Wittig-reactie met allyloxycarbonyl-
methyleentrifenylfosforaan plaatsvinden. Zo werd uiteindelijk de α,β-
onverzadigde esterfunctie van het macrolide geintroduceerd. 
De ringsluitingsreactie ¡s een essentiële stap in de synthese en hiervoor werd 
de Yamaguchi-lactonisatie toegepast. Na verwijdering van de 
beschermgroepen werd doelmolekuul 17 verkregen in 3% opbrengst 
uitgaande van D-mannose. 
o. 
3 + 1 2 
f^^OEE 0 
°
H
 d.e U . '·9 
14 OTBDPhS 
f^^OH О ; Ο ι О 
ч
^ ' \ ^ ' \ ^ \ ^ л < « о \ ^ ^ ^ \ ^ ν ^ ο ^ ^ ^ ^ ч ^ ^ о н 
1 5 OTBDPhS 1 6 OTBDPhS 1 7 ÖH 
α. 12, /7-BuLi, 3, THF, 50%; b. Η2, Pd-C, EtOAc; с. Na, NH3(I), 73% (2 stappen); d. 
РпэР=СНС(0)ОАІІ. CH2CI2; e. TBDPhSiCI, imidazool, 78% (2 stappen); f. MgBr2, Et20. 
82%; g. (PPh3)<Pd, morfoline, THF, 69%; h. 2,6-dichloorbenzoyl chloride, EtsN, THF, 
gevolgd door DMAP, Δ, tolueen, 53%; i. TFA/НгО/МеОН (1:5:14), 68%. 
Schema 4 
Tijdens deze synthese moesten een aantal problemen worden opgelost. De 
hydrogenolyse van de benzylgroep was het eerste probleem, maar dit kon 
worden overwonnen door behandeling met natrium in vloeibare ammoniak. 
108 
Samenvatting 
De tweede tegenslag was de intramolekulare Michael additie van de vrije 
hydroxylgroep aan de α,β-onverzadigde esterfunctie tot een mengsel van ci­
en ß-C-glycosides (schema 5). Met in situ bescherming van de vrije 
hydroxylgroep kon deze ongewenste reactie worden voorkomen. Een 
interessante vinding was dat de Michael-adducten ook konden gesloten tot 
een macrocyclisch lacton, nl. 20. 
OH y-OAII f^OEE 0 
>c 
14 OTBDPhS 
spontaan 
OEE 
.OAII b-d 
20 
a. TBDPhSiCI, imidazool ; b. MgBr2, Et20, 82%; с (PPhabPd. morfol ine, THF, 69%; d . 2,6-
dichloorbenzoyl chlor ide, ЕІзЫ, THF, g e v o l g d d o o r DMAP, Δ, t o l u e e n , 53%; 
Schema 5 
In dit hoofdstuk werd tevens de analyse gegeven van andere op 
monosaccharide gebaseerde syntheses van aspiciline. 
In hoofdstuk 3 wordt een alternatieve synthese route van het aspiciline 
beschreven waarbij het plan was een Wlttlg-reactie als uiteindelijke 
ringsluitingsreactie te gebruiken waarin het hemiacetaal van het 
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Samenvatting 
monosaccharide als aldehyde fungeert. Het reactieschema ¡s op 
retrosynthetische wijze in schema 6 weergegeven. 
•< А ' л « >ОН O ^ " \ ^Y* 
,νιΟθη 
21 
Schema 6 
Alhoewel het fosfoniumzout kon worden gesynthetiseerd, is deze poging 
vastgelopen omdat de benzylbeschermgroep niet kon worden verwijderd 
om het benodigde aldehyde vrij te maken. 
In hoofdstuk 4 wordt een aanzet tot de synthese van een l l-ring analoog, 23, 
van de natuurstof aspiciline beschreven (zie retrosynthese in schema 7). Voor 
deze voorgenomen synthese konden dezelfde bouwstenen 3, 7 en 24 als in 
hoofdstuk 2 voor de synthese van aspiciline gebruikt worden. 
o. 4 
OH OPrg 
23 
Schema 7 
Alhoewel het gebruik van deze uitgangsstoffen aantrekkelijk leek, werden 
ook dezelfde problemen als in hoofdstuk 2 waargenomen, nl. de vorming van 
een l l-ring "Michael-macrolide". 
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Rijswijk, 20 November, 1997 
Dear Colleagues, 
SPECS and BioSPECS -10 Years 
Ten years ago, we started our company with the founding concept to make available to 
industrial researchers the "compounds from the literature". As a trusted and respected 
intermediary, we have played an essential bridging role in bringing the compounds 
prepared in academic research programs to industrial research laboratories. 
Ten years on, we look back on a company that experienced dramatic growth based largely 
on the high throughput screening programs for biological activity that were introduced in 
the 'nineties in pharmaceutical and agrochemical companies. It became our core business to 
acquire and sell novel compounds that will one day become commercial products. It also 
meant developing a world-wide network of more than 10,000 chemists who prepare these 
compounds. 
That we were the first and that we remain the best in this business is a testimony to the 
people who work for our company. It is no accident that many of our key staff come from 
the University of Nijmegen. We take this occasion to pay special tribute to the staff in 
Nijmegen who produced so many capable people. 
Very best wishes, 
SÔECS and BioSPECS b.v. 
lib MA 
Richard L. Wife Pieter F. Fangman 
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The Hague 120308 
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